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Dwarfism is an undesirable phenotype in beef cattle that has reduced 
profitability for both commercial and pure bred producers since the 1950s.  In 2002, 
a flare up of dwarfism on several ranches across the US led to new genomic 
research designed to find the genetic mutation.  Linkage-mapping of Bos taurus 
autosome 6 (BTA6) indicated a LOD score of 7.34 between microsatellite markers 
AFR227 and BM4311.  To expedite the fine-mapping process, the BLAST Extension 
and Alignment Program BEAP was developed to assist with sequence assembly of 
the Angus dwarfism locus prior to completion of the bovine genome project.  Four 
positional candidate genes, bone morphogenetic protein (BMP) 2 kinase, bone 
morphogenetic protein (BMP) 3, fibroblast growth factor 5, and cGMP-dependant, 
type II, protein kinase (PRKG2), were re-sequenced using BEAP output as template.  
Within PRKG2, a C/T nonsense mutation was discovered (R678Z) that truncates 
PRKG2 by 85 amino acids (AA), including 25 AA of the kinase domain.  A mouse 
knockout model and naturally occurring PRKG2 mutants demonstrate that lack of 
PRKG2 function causes dwarfism.  Recent work in the rat indicates that PRKG2 
signals SOX9 to regulate the transition from proliferative to hypertrophic growth in 
the growth plate.  Gene expression data in the rat demonstrated that PRKG2 
mutants lose the ability to regulate SOX9 mediated collagen (Col)2 and Col10 
transcription.  To determine if the Angus R678Z PRKG2 mutation altered collagen 
expression, wild-type and R678Z bovine vectors were assayed in a cell culture 
transfection experiment.  Real-time PCR results confirmed that COL2 was 
inappropriately over-expressed in cells transfected with the R678Z mutation as 
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compared to cells transfected with wild-type PRKG2 (p<0.01).  Over-expression of 
COL2 in dwarf cattle was confirmed by real-time PCR of dwarf and normal cattle 
growth plate tissue samples (p<0.0001).  Expression of COL10 was found to be up-
regulated in dwarf animals as well (p=0.05).   These experiments indicate that the 
R678Z mutation is a functional mutation, resulting in a loss of PRKG2 regulation of 
COL2 and COL10 mRNA expression.  To determine if the R678Z marker was an 
accurate predictor of Angus dwarfism, we conducted a breeding experiment.  Six 
calves were produced by embryo transfer and their phenotype was predicted with 
100% accuracy prior to expression of the phenotype.   Four animals were predicted 
to be dwarves, homozygous for the R678Z PRKG2 marker, and two were predicted 
to be normal, heterozygous for the R678Z PRKG2 marker. Differences in skeletal 
growth were characterized by measurements of gross differences in height, long 
bone and vertebral column length. Animals homozygous for the R678Z PRKG2 
marker had shorter metatarsals (reduced 4.5cm; p<0.01), and fused ulna/radius 
(reduced 7.5cm; p<0.01) bones. No significant differences were observed between 
these animals for head length, calvarium (skull) width, or bone circumference 
(p>0.25).  Stature and body length were also compared between animals 
homozygous for the R678Z PRKG2 marker and the R678Z PRKG2 heterozygotes at 
approximately 210 days of age. Animals homozygous for the R678Z PRKG2 marker 
were 15.8cm shorter (p<0.0001) and had spinal lengths reduced by 20.7 cm 
(p<0.0001) (data not shown).  Transcriptional profiling of the null PRKG2 dwarf 
versus wild-type animals was performed using a 70 mer cDNA microarray to assess 
global changes in gene expression.  Both COL2 and COL10 were found to be 
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differentially expressed in the same direction and similar magnitude as observed by 
real-time PCR (p<0.05).  In addition, non-sense mediated decay of dwarf PRKG2 
and up regulation of Wnt5a, and collagen9, markers of proliferation, was observed 
(p<0.05).  Multiple genes were found to be differentially expressed in the MAPK and 
Wnt5a signaling cascades.  In addition, many Golgi transport and neuronally 
expressed genes were observed as differentially expressed.  These genes provide 
interesting candidates for understanding the intermediate processes in the PRKG2 
intracellular signaling pathway that regulate proliferation and developmental timing of 
the growth plate.  Implications of these discoveries will allow Angus breeders to 
eliminate dwarfism and present a model to study PRKG2 function in the growth 
plate.
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CHAPTER 1.  GENERAL INTRODUCTION 
INTRODUCTION 
The study of genetic diseases in livestock has application to both the medical 
and agricultural sectors of society.  Hereditary disorders in livestock represent 
naturally occurring disease models for dissection of underlying genetic factors in 
human congenital disease.  Since livestock models are preexisting, they are 
inexpensive, unlike rodent models, which often require costly transgenic lab work. 
Livestock provide insightful detail about genomic structure in comparative genomic 
analysis.  Furthermore, livestock provide a better model to understand the molecular 
pathogenesis of disease than traditional models, because they have comparable 
genomic complexity to that of humans [1].   
Within the livestock sector, the application of molecular genetics in the beef 
cattle industry has the potential to greatly boost revenues. Use of genetic tests could 
rapidly improve beef cattle production efficiency and profitability.  The greatest 
impact could be realized in the areas of animal health, genetic diseases, meat 
quality, and survival.  Gross receipts in the beef cattle industry represented the 
largest portion of the 2000 agricultural economy in the US [2].  Therefore, genetic 
tests could greatly enhance profitability in the beef industry and agricultural 
economy.   
Dwarfism is a genetic disease that has cost beef producers considerable 
profitability over the past 60 years.  Dwarf animals are subject to penalties at harvest 
or not marketable due to their small frame size.  Cattle breeders with suspect 
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dwarfism carriers often loose their livelihood due to the negative stigma associated 
with dwarfism.  Historically, breeders have identified and removed carrier animals 
based on the production of dwarf progeny, test matings, and relationship of dwarf 
parents by pedigree checking.  Unfortunately, these methods are not fully effective 
at identifying dwarf carriers for removal from the herd. Use of test mating was 
effective, but proved extremely expensive.  Ideally, a more accurate and cost 
effective assay, like a genetic marker, could be used to test for dwarfism.  
Development of a genetic test to remove dwarfism from the cattle population would 
help producers improve efficiency and prevent further economic losses.   
Initial research to identify the locus associated with dwarfism began at Iowa 
State University in the fall of 2002 following the appearance of several dwarf calves 
at ranches across the US.  First, Mishra and Reecy [3] tested the dwarf Angus for 
dwarfism mutations in the Japanese Brown cattle population [4].  These tests 
showed that Angus were wild-type for mutations in the LIMBIN gene, found to be 
responsible for dwarfism in Japanese brown cattle.  Next, DNA samples from dwarf 
Angus were sent to Australia for testing to determine if Angus dwarfism was caused 
by the same mutation(s) associated with Dexter dwarfism (unpublished data).  
Microsatellite markers associated with Dexter dwarfism were tested for loss of 
heterozygosity by homozygosity mapping.  Again, Angus dwarfism was not 
associated with these mutations (unpublished data).  Finally, a genome scan was 
undertaken to determine which chromosome harbored alleles associated with the 
dwarfism phenotype (Mishra et al., unpublished work described in chapter 2). Early 
in the analysis, Bos taurus autosome 6 (BTA6) was identified as the most probable 
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location of the dwarfism locus (LOD=7.34) under the assumption of a recessive 
pattern of inheritance.  Work completed by the author of this dissertation focused on 
fine-mapping and characterization of a nonsense mutation in the PRKG2 gene as 
the causative mutation for this strain of dwarfism. 
AIMS AND OBJECTIVES 
Our objective was to develop a genetic test to predict the dwarf carrier status 
of American Angus cattle.  Furthermore, it was our goal to characterize the 
functionality of the PRKG2 R678Z mutation on dwarfism to assess causality of the 
mutation.  Development of a genetic test to detect dwarf carriers will increase 
profitability for beef producers and increase the value of suspect dwarf carriers. 
Understanding the function of PRKG2 will be useful in finding medical treatments to 
prevent complications associated with dwarfism and may assist in the development 
of therapeutics to prevent dwarfism and treat other osteopathic disease in humans. 
THESIS ORGANIZATION 
 This dissertation presents the authors research in the alternative format.   
The first chapter contains a general introduction and a review of literature relevant to 
described research.  The scope of this dissertation bridges the application of 
linkage-mapping techniques and functional analysis of a mutation in the PRKG 
gene.  Therefore, the literature review is split into three main sections.  The first 
section describes important factors in a linkage-mapping experiment.  The second 
section discusses the biology of bone growth and various diseases ranging from 
dwarfism to mineral metabolic diseases with potential relevance to the function of 
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PRKG2.  The last section of the literature review describes the majority of what is 
know about the function of PRKG2. 
Chapters 2 through 4 are papers in preparation for publication.  Chapter 2 is a 
manuscript describing the linkage-mapping and identification of the mutation that 
causes dwarfism in Angus cattle to be submitted to Genome Research for 
publication.  Chapter 3 is a manuscript in preparation for submission to BMC 
Bioinformatics describing the development of software package for assembly of 
small portions of a genome.  Chapter 4 is a manuscript that describes transcriptional 
profiling of dwarf versus normal cattle to determine the consequences of a loss of 
function mutation in PRKG2 in the growth plate that will be submitted to the journal 
Physiological genomics. Chapter 5 consists of general conclusions of the research 
presented in this dissertation.  In Chapters 2, 3, and 4, the contributions of the 
authors were as follows: J.E. Koltes was the primary researcher and author of all 
chapters, under the direction of J.M. Reecy.  The publication comprising chapter 2 
was assisted by collaborative work from B.P. Mishra (coordination of initial 
microsatellite genotyping, DNA isolation, LIMBIN genotyping, pedigree construction), 
D. Kumar and R. Kataria (RNA isolation and real-time PCR analysis), L.R. Totir, and 
R.L. Fernando (development of statistical software, initial statistical analysis), R. 
Cobbold and D. Steffen (diagnosis of dwarfism and pathology), and from W. 
Coppieters and M. Georges (oversight of microsatellite marker genotyping and 
selection). Work described in chapter 3 on BEAP was assisted by E. Fritz and 
performed under the direction of Z-L Hu.  Dr. Hu wrote all perl scripts and assisted in 
all diagnostic tests of the software. Work described in chapter 4 was assisted by 
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collaborative work from V. Cooper (assistance with dissection and analysis of gross 
pathology. 
REVIEW OF RELEVANT LITERATURE 
History of bovine dwarfism 
 Dwarfism has been a problem in the beef cattle industry for nearly a century.  
Many breeds have been reported to have dwarfism, including: American and 
Australian Angus, Brahman, Dexter, Jersey, Hereford, Holstein, Japanese Brown, 
Shorthorn, and South Devon [5-11].  The most thoroughly reported dwarfism, 
historically, has been Hereford dwarfism.  L.P. McCann wrote a book, The Battle of 
the Bull Runts, to discuss the influence of dwarfism on the Hereford breed [12].  The 
United States Hereford association spent decades funding research to detect 
carriers of dwarfism.   Notably, Drs. Jay Lush and Lanoy Hazel of Iowa State 
University devoted a considerable amount of time and research assisting Hereford 
association in this endeavor.  Dr. Lush was a consultant who spoke often at board 
meetings and described the recessive form of inheritance.  He also provided insight 
to Mr. McCann on the difficulty of finding the founder who originally spread dwarfism 
to the breed.  Dr. Hazel sat in on many of Dr. Lushs meetings with the Hereford 
association.  Hazel conducted research to determine if X-ray technology could be 
used to differentiate between dwarf carriers and normal cattle.  Both Dr. Lush and 
Hazel coordinated efforts at Iowa State to test promising scientific assays that might 
be capable of determining dwarf carrier status. Unfortunately, no laboratory test was 
found to diagnose an animal as a dwarf carrier.   
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The quest to find and eliminate the cause of dwarfism was a costly venture.  
McCann wrote in his book that, it is likely no other project in the history of animal 
science had so many researchers and so much time and effort invested in it across 
the US as the effort to find a test [to remove dwarfism from Hereford cattle].  In fact, 
the process drew great interest, even from President Eisenhower who had dwarf 
Angus cattle on his ranch.  Dwarfism cost farm familys their livelihood as breeders 
of seed stock cattle and cost the beef industry millions of dollars in the 1940s-50.  
Finally, after years of work, dwarfism was greatly reduced by the early 1970s by 
searching pedigrees of animals that were ancestors of dwarf producing cattle.  
Eventually, the bull St. Louis Lad, born in 1898, was determined to be the likely 
founder of the disease in Hereford.  While the work to search pedigrees did remove 
most dwarf carriers, the Hereford breed has experienced periodic flare-ups of 
dwarfism, because not all carriers could be determined by pedigree.  Some breeders 
decided to use test mating to find carriers of dwarfism, but this is a very slow and 
costly process to produce the required number of animals to deem an animal as free 
of dwarfism.  Dwarfism in Angus cattle began appearing in the late 1940s and early 
1950s.  Many of the tactics learned by Hereford breeders were quickly adopted by 
Angus breeders to curtail the problem in Angus.  It was always hoped that someday 
a less costly, more effective test would be developed to determine carriers of 
dwarfism to help cattle breeders remove dwarfism for once and for all. 
 7
DETECTION OF MAJOR GENE MUTATIONS 
Overview 
Scientists have sought out genomic regions responsible for phenotypic 
variation in traits for more than 80 years.  Payne and Sax were among the first to 
perform linkage-mapping experiments in search of quantitative trait loci, QTL [13, 
14].  Considerable research has been done to compare statistical models for the 
best linkage-mapping methods [15-20].  The ultimate goal of any linkage-mapping 
project is to find the causative mutation(s) underlying the variation in a phenotype.  
Depending on the species and the phenotype, the challenges involved in this 
process vary considerably.  One major challenge is genome characterization, as 
some species have fully sequenced genomes with plentiful markers while other 
species have few genomic resources available.  Regardless of the species, finding 
the causative mutation(s) for a phenotype of interest can be like looking for a needle 
in a haystack.  
 Detection of major gene/causative mutations has considerable importance to 
society.  In fact, the ability to test and harness causative mutations is already being 
used to enhance animal breeding and human medicine [21, 22].  The proliferation of 
genetic marker types and whole-genome sequences has provided a plethora of 
markers for linkage analysis.  Whole-genome single nucleotide polymorphism (SNP) 
chip panels (SNPchips) are now available to genotype in excess of one million SNPs 
on platforms such as the Illumina bead array (http://www.illumina.com) [23].  Without 
limitations in marker density, the ability to quickly linkage map QTL and disease loci 
to smaller and smaller genomic regions is now possible.   
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The objective of this section is to explore important considerations in linkage-
mapping of major gene mutations and to describe statistical methods to accomplish 
this task.  A major gene mutation is defined here as having two distinct phenotypic 
distributions based on inheritance of a mutation at a single locus (i.e. Booroola locus 
for fecundity; [26]).   Many of the assumptions and methods made for QTL mapping 
will apply to all major gene mutations.  In the case of traits that fall into distinct 
categories, e.g. dwarf- yes or no, statistical methods must be changed to account for 
a unique phenotypic distribution in linkage-mapping.  The following sections will 
describe considerations required when linkage-mapping major gene mutations. 
Linkage and linkage disequilibrium  
Linked markers are on the same chromosome and are physically close 
enough that they are often inherited together in blocks, because they are not likely to 
be broken apart by recombination during the process of meiosis.  There are levels of 
linkage ranging from complete linkage, whereby marker alleles always segregate 
together, versus incomplete linkage, where markers are at distances far enough 
apart that recombination can occur between them. Markers are considered unlinked 
when their co-segregation is random.  Recombination rate is used to estimate the 
map distance between markers on the chromosome.  Map distance is used to 
calculate the true distance between markers as it accounts for double recombinants 
which cannot be observed when counting the number of recombinations between 
markers.  Various functions are available to model the relationship between 
recombination rate and map distance, including the Haldane function (no 
chromosomal interference between recombination events during meiosis) and the 
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Kossambi function (complete interference between recombination events).  
Additional details on these models are described in [27] and [28].   
Linkage disequilibrium (LD) is the non-random association of marker alleles at 
two loci deviating from the expected genotype frequencies given the recombination 
rate and Hardy-Weinberg equilibrium (HWE).  The equation to calculate LD is 
P(A)*P(B) ≠ P(AB), where P(A) and P(B) are the marker allele frequencies at two 
different loci and P(AB) is the observed genotype frequency [29].  When these terms 
are not equal the markers are said to be in LD.  Various methods have been 
developed to measure LD [30], but they will not be described in depth here.  It is 
possible for LD to exist both at close and distant markers across chromosomes.  The 
forces causing LD are many and varied.  Breed crossing, drift, migration, mutation, 
selection, and inbreeding are some of the forces that can lead to LD between 
markers.  Without LD, it is difficult to narrow the region containing a causative 
mutation in a population without a pedigree structure, because there is no way to 
account for recombination.  Paradoxically, if LD is present over large distances, such 
as in an F2 cross, it becomes difficult to narrow the region containing a true 
causative mutation. Experimental crossing schemes, like advanced intercross lines, 
AIL, can be used to alleviate this problem using recombination to erode LD.  (AIL is 
described in more detail below.)  The use of linkage versus linkage disequilibrium 
(LD) for mapping QTL has been explored extensively [16, 18, 31-36]. Combined 
linkage and linkage disequilibrium methods have been used to account for and 
capture useful linkage disequilibrium for narrowing the location of causative 
mutations [34, 36, 37, 39].   
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Factors in experimental populations that influence efficiency in finding major 
gene effects 
The ability to detect a major gene effect is dependant upon the ability to track 
a mutations inheritance from generation to generation by linkage or using close 
markers in association with the phenotype by LD with the true mutation.  Therefore, 
family structure, Hardy-Weinberg factors, phenotypic information, mutation allele 
frequency, segregating genetic variation and heritability greatly influence the ability 
of a major gene to be detected.  In addition, the ability to track down a major gene 
effect is greatly influenced by marker spacing and information content.  Ideally, 
major gene mutations would have complete penetrance, no variable expressivity, 
and would not be influenced by polygenic or environmental influences.  In the real 
world, this is not always the case.  Often, it is necessary to make these assumptions 
anyway, because there are often no clear solutions in modeling these problems. The 
remainder of this review will consider these ideal cases (i.e. simply inherited 
recessive or dominant disease phenotypes). It is important to note that statistical 
accommodations can be made for these real world scenarios; however they can be 
computationally prohibitive and dependant upon additional population assumptions 
[15, 19, 38].    
A.  Factors that affect fine-mapping efficiency 
Factors that disrupt Hardy-Weinberg Equilibrium (HWE) 
 Factors influencing HWE include mutation, migration, drift, selection, fitness/ 
viability, and inbreeding (random mating).  Each of these factors can influence the 
ability to detect the effect of a mutation by linkage analysis [19].  All of these forces 
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alter genotype frequencies, altering linkage-mapping efficiency.  The influence of 
mutation is often very low, because the rate of mutation in the genome is quite low 
even over multiple generations [29].  Migration can create genetic backgrounds that 
alter the expressivity or penetrance of a major gene.  Mixing of population creates 
admixture, which can be useful to linkage-mapping or detrimental.  For example, 
some methods have harnessed admixture to detect major gene mutations because 
of the LD created between the mutation and flanking markers [17].  Drift, selection 
and inbreeding can lead to increased homozygosity and decreased effective 
population size, as well as increased linkage disequilibrium or both in a population.  
Increased homozygosity will lead to decreased marker information content to find a 
major gene mutation in a half-sib or granddaughter linkage-mapping design.  
Increased family sizes in mapping populations and multiple generation pedigrees 
can be used to overcome these problems by increasing the number of 
recombinations between flanking markers and the causative mutation. Other 
methods to account for deviations from HWE have been considered as well [40]. 
Phenotypic measurements 
 The method or type of phenotype collected for a specific trait can influence 
how easily a major gene or QTL effect can be detected.  Phenotypes need to be 
measurable with little measurement error to reduce variation due to technical error.  
This will alter the bias the estimate of a major gene effect.  In some cases, (e.g. 
dwarfism) detailed anatomical pathology should be measured to better define a 
phenotype.  There are hundreds of forms of dwarfism characterized by minor 
differences in pathological phenotype.  It would be easy to group together subtly 
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different dwarfisms, caused by different mutations.  In this case, it[J3] would be 
difficult to fine-map a causative mutation, because different dwarfisms would have 
different disease haplotypes.  In cases, it is better to take multiple measurements or 
phenotypes for a trait to better define the biology of a disease or specific trait [41].  
Different measurements have subtly different environmental and biological 
influences on a trait (e.g. back fat measurements in livestock).  With certain cases of 
disease, like mastitis, it is often useful to specify to the level of the pathogen or 
immunological response involved in a specific type of infection to improve heritability 
[42].     
B.  The influence of experimental design on fine-mapping 
The population available for genotyping is an important resource for finding 
major gene mutations.  A family structure is required to follow the co-segregation of 
a specific marker allele with a major gene mutation to perform linkage-mapping.  In 
livestock, family structure and artificial selection pressures play a large role in 
populations available for major gene detection.  Pedigrees are available for some 
populations, providing a predictable means to follow inheritance of both a marker 
and a phenotype from parent to progeny.  A pedigreed population is a requirement 
for linkage-mapping, but does not have to be pre-existing.  Specific crosses can be 
experimentally designed between lines with different selection pressures and genetic 
backgrounds to detect major gene effects.  In some cases, a population structure is 
not required to detect major gene effects if large populations can be genotyped for 
markers close to causative mutations, like in the candidate gene approach 
(association study) or homozygosity mapping methods [43, 44].  The method of 
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choice to detect major gene effects varies depending on the populations available 
and species specific breeding schemes.  The number of individuals needed to detect 
a major gene effect varies based on the marker information available, number of 
individuals available in each genotype class to genotype, marker spacing, and 
possibly the extent of LD.  Methods to determine power in QTL mapping 
experiments can be found in the following references [15, 19, 45].  The individuals 
with available DNA for study ultimately influence the population and method used to 
detect a major gene mutation.  In addition, the phenotypic distribution, normal or 
binary, greatly alters the method used to find a major gene.  When multiple 
generations of related individuals are available, linkage-mapping is possible.  Unless 
the population is large, LD information is often not effective in finding a major gene.   
Experimentally designed crosses 
 Experimentally designed matings are another method to fine-map genomic 
regions containing major gene mutations.  Breed crosses, such as F2 or backcross, 
are commonly used in QTL experiments [46, 47].  Both methods increase the 
amount of LD available for detection of major genes.  In the backcross design, 
affected lines are repeatedly crossed to an unaffected line to enrich genomic regions 
harboring causative mutations for the trait. Backcrossing is often used to determine 
the mode of inheritance with newly discovered major gene effects [48, 49].  The 
extended application of backcrossing in a backcross population can be used for the 
introgression of genomic regions in the development of nearly isogenic lines (NIL) 
used in model organisms like mice and rats [50].  These methods have been fruitful 
for the detection of QTL [51].  To overcome LD in F2 populations, advanced 
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intercross lines (AIL) and recombinant inbred lines (RIL) are experimental methods 
used to create populations with reduced LD between markers and major gene 
mutations [52].  Such crosses maximize the available recombination for linkage-
mapping by repeatedly crossing divergent lines.  This results in increased 
observation of recombination between loci and narrowed localization of linkage 
disequilibrium to small regions across the genome.  These designs work well in 
plants, but can be difficult to apply in animals due to generation interval lengths, 
inbreeding, and cost. Breeding experiments have been designed to use only 
recombinant sires to generate additional progeny for linkage-mapping, e.g. mapping 
of Myostatin mutation for double muscling in Texel sheep [53].   The disadvantage of 
planned crosses is that they can become costly, especially in livestock where 
generation intervals are often lengthy. 
 Existing populations 
Some populations have existing population structure that is useful for linkage-
mapping.  In pigs, large full sib families are often available.  In dairy cattle, large 
outbred half-sib families are often available because of artificial insemination and 
progeny testing systems [54]. In some cases when LD is a concern, historical 
recombination can be used to assist in linkage-mapping if multiple generations of 
ancestors can be genotyped and have known phenotypes [34].  With increased 
number of generations between founders and affected individuals, more 
recombinations and Mendelian samples of the founder haplotype occur across a 
wide range of genetic backgrounds.  This mixing of genetic content provides 
increased opportunity to erode LD between markers that are far away from the 
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mutation versus markers near the mutation.  This is similar to the effect caused by 
the creation of an AIL.  When common ancestors are identifiable, identical by decent 
(IBD) segments can be traced from generation to generation along the use of 
combined linkage and LD methods.  In dairy cattle, IBD, daughter, and grand-
daughter designs have been used routinely for linkage, LD and combined mapping 
methods [34, 45].   A variety of IBD methods have been used in humans [35, 55].  
Unfortunately, family sizes are often small for human populations and phenotype 
and genotype information for multiple generations within a pedigree are often not 
available.    
Requirements of molecular marker data for mapping of major genes 
In order to detect marker trait associations, it is critical to maximize the amount of 
information that can be gleaned from the population/pedigree at hand.  Marker 
density, spacing, heterozygosity, and available polymorphism greatly influence how 
much information can be obtained about any portion of the genome. Accurate 
genotyping influences how well inheritance of a major gene mutation can detected 
[56].  The following passages will discuss how these factors alter the ability of 
researchers to track down and detect major gene mutations.   
A.  Marker density 
Marker density is another factor that determines how narrow a region a QTL or 
major gene effect can be mapped within.  There are limits to how dense markers can 
be placed due to cost [57], available information from a marker, due to LD, and the 
assay used for genotyping. However, cost and assay will likely become unimportant 
in the near future with the proliferation of SNP markers discovered in whole genome 
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sequencing projects and new genotyping platforms available.  The number of 
markers needed to linkage map has been explored and depends on the genome 
size and the distance between markers and causative mutations on average [58, 
59].  In the case of LD mapping, the number of markers needed varies with the 
amount of LD between markers in the mapping population.  When many markers are 
tested, the odds of detecting linkage to a major gene mutation or QTL by chance 
increases.  Therefore, a variety of tests have been suggested to account for the bias 
that multiple testing may introduce to a linkage-mapping study.  The most commonly 
used methods include Bonferroni correction, permutation testing, and false discovery 
rate (FDR), with the FDR method being favored [63].   
B.  Marker information content 
Without informative markers, density is of no assistance in finding a major gene 
mutation.  Calculation of information content can be found as described [60].  An 
informative marker is one that can be used to distinguish parental chromosomal 
blocks from one another in either LD or linkage-mapping analyses.  Informative 
markers can be traced from parent to progeny such that the exact allele inherited 
from a single parent is known in the offspring.  In order for a marker to be 
informative, it must be heterozygous in the parents.  Closely tied to information 
available is the polymorphism of a given marker.  For example, microsatellite 
markers are more polymorphic than SNP markers making it easier to differentiate 
between parental alleles in the offspring.  The tradeoff is that microsatellite markers 
are not as frequent in the genome as SNP markers and are more expensive to 
genotype per marker.   
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Statistical methods to find major gene mutations 
A.  Overview 
Statistical methods to map major gene mutations are often selected to fit the 
population and trait to be analyzed.  Ideally, a researcher can perform planned 
matings to maximize the power desired to detect a major gene effect.  Many times, 
such experiments are cost prohibitive.   A variety of statistical methods have been 
developed to fine map major gene mutations.  Least squares regression [61], 
maximum likelihood [60], and Bayesian [16] approaches have been used to detect 
QTL.  However, these methods are not always appropriate for detection of marker 
associations with binary traits.  The remainder of this section on major gene 
detection will focus on statistical methods to find monogenic, one, or oligogenic, 
several, major gene effects as performed with the Angus dwarfism pedigree. 
Mutations with major gene categorical effects can be detected using many of 
these methods, but special adaptations have been developed to account for the 
pattern of inheritance.  The use of single markers can be employed by Transmission 
disequilibrium test (TDT) [62].   Homozygosity, identity-by-decent (IBD) mapping, is 
another method that has been used extensively to find disease genes that follow 
Mendelian inheritance [32, 44].  These methods can be used to perform interval 
mapping or to assess larger haplotype blocks to identify IBD chromosomal blocks 
using combined linkage and LD analyses.  The candidate gene method could also 
be used to detect such a mutation, assuming the pattern of inheritance is known 
[43].   
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B.  Elston-Steward algorithm 
 The Elston-Steward (ES) algorithm is a method well-suited to find major gene 
mutations that have a binary phenotypic distribution.  It was originally developed as 
a means of pedigree based analysis of genotype frequencies [64].  Ott [65] 
developed a model-based linkage method using both phenotypic and genotypic 
information in human pedigrees under the assumption of monogenic or oligogenic 
inheritance [64].  This model simultaneously accounted for all genotype possibilities 
and the phenotype of individuals with the pedigree.  The ES method can be used for 
many different applications, including linkage-mapping [65].  The method works well 
with small pedigrees, but becomes computationally exhaustive with large pedigrees 
and markers with three or more alleles.  The ES algorithm is particularly useful 
when maximum information needs to be gleaned from small pedigrees with missing 
phenotypes and genotypes.  However, the method becomes computationally 
extensive when pedigrees contain loops, e.g. common ancestors. 
 Extensions of the ES algorithm can be used to linkage-map QTL or disease 
genes when pedigrees contain loops [64, 66, 67, Totir and Fernando, unpublished 
data.)  This method calculates a likelihood of odds (LOD) score for each marker 
interval, two marker haplotype, based on phenotype status and available genotype 
information.  The log base 10 of this likelihood ratio (mutation in a marker haplotype/ 
mutation on another linkage group) is the LOD score.  A LOD score great than 3 is 
typically considered statistically significant. Likelihood ratios for linkage-mapping 
are calculated assuming the causative mutation is located at the center of the 
flanking markers as compared to likelihood that the mutation is on another 
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chromosome. These likelihood functions account for all possible genotypes at the 
disease locus. Each Likelihoods (L) is calculated  
 
 
where Pr(y) is a vector of dwarfism phenotypes, and Pr (G ) is a vector of genotypes 
at the markers flanking the interval and the dwarf mutation for all individuals in the 
pedigree.  The Likelihood calculated accommodates all possible genotypes 
assuming a user specified disease allele inheritance pattern.  If the disease locus 
genotype is not known, then the probability of having a copy of the disease allele for 
founders can be estimated or assigned assuming HWE and no relationship among 
founders.  For all non-founders, the probability of carrying the disease allele can be 
calculated as 
Pr(gi|gf,gm) 
where gi is the probability of individual i having one copy of the disease allele given 
the probabily of the mother, gf, and father, gm having the disease allele.  Non-
founder genotype probabilites are  calculated using genotype probabilites calculated 
using the allele frequencies in the founder population.  The probability of being any 
of the possible genotypes for a marker can be estimated using these formulae. 
Differentiating between a causative mutation, direct vs. indirect markers 
 Determining causality of a mutation detected by linkage-mapping requires 
both statistical and functional molecular biology evidence.  Statistical evidence, 
besides providing a significant probability of detection should also involve 




Functional biological data also needs to be provided to show that a marker is not 
segregating by chance or in linkage or linkage disequilibrium with a true causative 
mutation.  The nature of this evidence varies greatly with the trait of interest.  A 
variety of technologies could be employed including biochemical assays, 
transgenics, microarrays, and cell culture to determine the influence of a mutation on 
biology. Knockouts, conditional mutants and over expression models are often 
considered the gold standard of demonstrating how a mutation can alter a 
phenotype in vivo in model organism.  These technologies are costly, and 
sometimes not possible in livestock.  Examples of identified causative mutations in 
livestock have been documented rarely and include Booroola [68], BLAD [69], CLPG 
[70], CVM [71], DGAT1 [72], F18 [73], IGF2 [74], Inverdale [75], LIMBIN [4], MC4R 
[76], MSTN [53, 77], PRKAG3 [78], and RYR [79].  
Using markers in selection schemes 
 Determining the value of a genetic marker depends on the type of marker and 
the selection scheme to be implemented.  The details of selecting a direct or indirect 
marker will not be discussed in depth here, but can be found in a review by Dekkers 
[21].  Both types of markers can be used; however, the implication and impact of a 
direct marker is faster.  If desired, an economic value could be assigned to a 
causative mutation for a disease mutation, e.g. dwarfism, and a molecular score 
could be designated for the marker.  In the case of dwarfism, since the allele 
frequency is relatively low in the population, it is not feasible to make such an 
accommodation.  The example of BLAD in Holstein dairy cattle is a case where 
including the marker in the index would have been productive because of the high 
 21
frequency of the BLAD disease allele in the Holstein population.  In the case of a 
genetic disease, such an index would balance the use of superior parents genetic 
backgrounds with the deleterious impact of the genetic disease. A summary of 
current use of markers for selection in livestock was described by Dekkers in 2004 
[21].  Future selection schemes in livestock will likely use genome selection methods 
or adaptations to allow selection upon many direct and LD markers simultaneous 
[25]. 
BONE GROWTH AND DEVELOPMENT 
Overview 
Early bone development lays the foundation for proper skeletal formation.  Bone 
precursor cells are derived from three distinct lineages of the paraxial mesoderm.  
These lineages include the somites, which form the axial skeleton, lateral plate 
mesoderm, which forms the limbs, and cranial neural crest, which forms the 
branchial arch and cranial facial bones.  These mesenchymal condensations 
proceed through development by one of two general methods.  Craniofacial skeletal 
structure and the clavicle are examples of bone that develop directly from 
mesenchymal cells through a process called intramembranous ossification.  Long 
bones of the axial skeleton and vertebrae are derived from cartilage through the 
process of endochondral ossification.  Endochondral ossification occurs at the 
growth plate between the diaphysis (bone shaft) and epiphysis (bone head) by 
transitioning cartilaginous tissue to bone in the growth plate.  
The growth plate is characterized by a distinctive region of ordered, 
developing cartilage cells.  In the growth plate, chondroblasts are prepared for their 
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transformation from proliferating cartilage to hypertrophic cells that direct the 
process of differentiation into bone [80]. Limbs are formed by a limb buds in 
vertebrates, which represents all of the cells that can become a limb.  Patterning of 
the limb fields in proximal/distal, anterior/posterior and dorsal/ventral coordinates is 
regulated by morphogenetic gradients of gene expression.  Timing is critically 
important to this process.  Additional details on limb development will not be 
discussed here, but can be found in the following references [81-83]. Errors in the 
process of endochondral ossification have been previously been implicated as the 
cause of achondroplasia [84-87]. 
Cell types involved in the physiology of bone growth and development 
 The construction of bone is much like that of highway.  There are key 
structural components that keep the bones solid and strong, yet flexible to handle 
wear and tear.  Bone is composed largely of mineralized extra cellular matrix,[J10] 
and cells, i.e. chondroblasts, chondrocytes, osteoblasts, osteocytes, and 
osteoclasts.  Depending on the type of bone, more or less of these cell types may be 
present.  Chondroblasts and chondrocytes act as the scaffold for building bone in 
the process of endochondral ossification.  Osteoblasts are early bone cells that 
colonize the cartilage to begin secreting extracellular matrix (ECM) and osteoid, the 
cement of the bone.  Osteocytes are mature bone cells that maintain ECM and living 
bone.  Osteoclasts remodel the bone, and are vitally important to bone turnover and 
replenishing of osteoid minerals that keep the bone strong.   
Bone structure dictates much of its function. The vast majority of bone, about 
80%, is composed of Haversian canals surrounded by concentric lamellae filled with 
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osteoid in the diaphysis, bone shaft.  This comprises the cortical bone and 
periostieum, where the bone is widened in a process called appositional growth.  
Here the bone is laid down opposite of the existing periostieum, the hard outer 
covering of the bone.  The remaining 20% of bone is made primarily of trabecular, 
a.k.a. cancellous, bone found primarily in the epiphysis.  This portion of bone has the 
greatest surface area and the majority of bone turn over occurs here.  Bones are 
innervated and vascularized through the Haversian canals; however, cellularity of 
bone is low.  Therefore, it takes considerable time to transfer nerve impulses and 
nutrients to bone.  
The ability to transport ions and nutrients throughout a bone is important for 
mineral and ECM turnover.  This process of replenishing minerals and structural 
components helps keep bones strong.  The Bone Metabolic Unit (BMU[J11]) can be 
thought of as the remodeling unit in charge of this process.  The BMU is composed 
of osteoclasts and osteoblasts.  Osteoblasts release paracrine factors that direct 
osteoclasts for bone remodeling.  Osteoclasts reabsorb the ECM, including 
collagens and minerals, resulting in hollowed pockets that osteoblasts will fill in with 
osteoid to create new bone.  Mineral homeostasis is tightly regulated by the body to 
allow for successful bone turnover.  Calcium metabolism is particularly critical to 
maintaining healthy bones.  This system is tightly controlled by a feedback loop 
initiated by vitamin D metabolism in the liver.  Based on the amount of the catabolite 
25-OH-D-1alpha, the kidneys, bone, intestines and parathyroid glands work together 
to alter the amount of calcium gleaned from the system. Calcium is one of the key 
components of hydroxyapatite, another key structural compound to maintain bone 
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strength. Errors in this process result in osteoporosis and other bone density 
diseases that lead to reduced bone strength [88, 89].   
Growth Plate development and organization 
A.  Overview 
Endochondral ossification is the process that allows bones to grow and 
expand in length from embryonic development until maturity during the life of a 
vertebrate.  Endochondral ossification occurs in two locations; at primary, diphyseal, 
and secondary, epiphyseal, sites.  The axial skeleton and long bones develop upon 
a cartilage scaffold in this process.  As mentioned, chondroblasts are originally 
derived from aggregates of mesenchymal cells [90, 91]. These cells differentiate into 
two types of cells that form cartilage elements and perichondrial cells.  These 
cartilage elements form the basis of the growth plate.  Chondroblasts, early cartilage 
cells, progress through proliferative and hypertrophic phases of growth.  As 
chrondrocytes proliferate and proceed to differentiate through the growth plate, they 
constantly act as a foundation for bone deposition until the growth plate closes and 
long bone growth ceases.  In particular, the process of hypertrophic differentiation 
drives and closely regulates how the growth plate develops and subsequent bone is 
formed. Therefore, proper endochondral ossification is required for the growth plate 
to develop in an orderly fashion to prevent skeletal malformation [88, 92, 93]. 
B.  Endochondral ossification 
The molecular mechanisms involved in endochondral ossification proceed in 
a time dependent and critically systematic order in the growth plate.  Chondrocytes 
in the growth plate undergo changes that allow a population of progenitor cells in the 
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resting phase of the growth plate to develop sequentially into proliferative, 
prehypertrophic, hypertrophic, and then terminally differentiated hypertrophic 
chrondrocytes. Vascularization of the hypertrophied growth plate allows for 
colonization of osteoblasts and osteoclasts.  These osteogenic cells trigger 
apoptosis of the terminally hypertrophied chondrocytes.  Osteoblasts create the 
foundation for bone to be created on top of the scaffold left by the dying 
chondrocytes.  It is this ordered gradual development of proliferative to hypertrophic 
chondrocytes or mature cartilage cells, which characterizes the growth plate.  As the 
chondroblasts differentiate, they proceed in an orderly columnar array of cells that 
radiate from the epiphysis to the diaphysis.  These chondrocytes secrete both type II 
collagen and aggrecan to create a suitable extracellular matrix for osteoblast 
development [94]. The end product is a post-mitotic, hypertrophic chondrocyte 
destined to undergo apoptosis.  The extracellular matrix of the chondrocyte is now 
ready to act as a scaffold for the deposition of bone with the assistance of 
chondroclasts.  Chondroclasts are specialized cells involved in calcification, and 
extracellular matrix remodeling of hypertrophic chondrocytes.  The dead 
chondrocyte now can act as a site for the development of osteoblasts into 
osteocytes.   
The resting zone, a source of growth plate chondrogenic progenitors 
 In reality, the synergy between growth plate markers is so critical to the 
development, that each marker could be thought to play a role in each growth phase 
due to the importance of timing.  The factors with the most dramatic effect within a 
growth region will be focused on.  The resting zone is an unorganized collection of 
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pre-proliferative chondrocytes.  They act as a reservoir for chondrocytes that will 
proceed through the growth plate during the endochondral ossification process.  The 
resting zone of chrondrocytes is sustained by bone morphogenetic protein (BMP) 2, 
parathyroid hormone like peptide (PTHlh, formerly named PTHrP) and Indian 
hedgehog (IHH).  It is the combination of these markers that help to drive 
chondrocytes from this resting zone to an actively proliferative state. These cells 
become more chondrogenic in organization and morphology as they migrate 
towards the growth plate [82, 95, 96]. 
Proliferative growth zone 
 The proliferative zone of the growth plate is closely tied to the resting and 
hypertrophic zones[J12] in timing and ordered progression of development.  Indeed, 
the same growth factors, BMP-2, PTHlh and IHH, are crucial to how and when 
proliferative chondrocytes will proceed through the growth plate.  Increased 
expression of IHH and BMP delays maturation and prolongs the proliferative state. 
However, these genes work in independent pathways [96].  Likewise, the levels of 
inhibitors of these pathways (e.g. BMPs inhibitor noggin) have the opposite affect, 
leading to decreased proliferation. The role of BMPs is often related to differentiation 
[97].  Excellent overviews of BMP function are presented by Hoffman and Gross 
(2001) and Wan and Cao (2005).  The proliferative chondrocyte has a round 
morphology and produces type II collagen for the ECM as they begin to stack into 
columns of chondrocytes. In the most common form of achondroplasia, which is 
caused by mutations in the FGFR3 gene, the proliferative zone of growth is greatly 
reduced in size resulting in shortened limbs, decreased number of proliferative cells 
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and achondroplasia [98].  Additional proliferative growth markers include: BMP7 [95], 
collagen 2 (COL2) [99], and p57Kip2 [100].   
Hypertrophic growth zone 
 As the cells progress through the proliferative state, their profile of gene 
expression changes, which leads to a switch from the proliferative to hypertrophic 
state.  Many molecular factors are beginning to be explored; however, only a few 
critical pathways have been dissected in great detail.  Several studies have utilized 
transcript profiling to identify possible mechanisms that control chondrocyte 
hypertrophy [101-103].  Additional research of these pathways may provide insight 
into critical pathways that control bone elongation. Among the most characterized 
intracellular signaling pathways are FGFs and TGFβs.  The role of type 10 
collagen[J13] (COL10), an ECM component, has also been investigated thoroughly.  
The FGFs have been explored extensively, because of the FGFR3 achondroplasia 
models for human dwarfism.  Without proper FGF2 regulation, as occurs in the 
FGFR3 mutants, chondrocytes show decreased proliferation and limbs are 
shortened due to decreased growth.  As chondrocytes mature, they proceed from a 
prehypertrophic to a terminally differentiated state.  The expression of Spp1 and 
MMP13 is critical to reaching this fully differentiated state [95].   FGF2 regulates IHH 
and COL10 mRNA expression levels.  Expression of these markers regulates both 
proliferative and hypertrophic growth in chondrocytes [104].  The role of IHH has 
been discussed previously [105]. COL10 is a particularly important marker as it is an 
important structural transition into the prehypertrophic state. Without type 10 
collagen expression, the extracellular matrix would not be properly prepared for 
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mineralization (including calcification) and ossification by chondrocytes [106, 107].  
In fact, mutations in COL10 have already been shown to be responsible for 
chondrodysplasias in the mouse, and pig [108-110].  The role of IHH is constant 
through out the entirety of growth phases and critical in regulating a host of growth 
factors in the growth plate [95, 96].  Considerable research with TGFβs has been 
explored.  The role of TGFβs appears to be inhibition of hypertrophy in general, but 
this may be in part due to up regulation of PThlP [111, 112].  Additional hypertrophic 
growth regulators include: Alkaline phosphatase (ALP) [113, 114], BMP2 [96], Distal-
less homeobox 5 (Dlx5) [115], Dlx6 [116], MMPs [117, 118], and osteopontin (OPN).  
C. Overview of additional growth regulators in endochondral 
ossification 
 Growth regulators involved in endochondral ossification could be split into 
additional functional groups, such as chondrogenic, global growth, osteogenic, and 
vascular developmental markers.  Some growth regulators have multiple functions 
within this classification.  Table 1 provides a list of several additional noted genes 
and gene families with important roles as bone growth regulators.  An even wider 
range of gene families involved in chondrogenic development could be added to this 
list, including notables such as noggin [120] and the Wnt signaling pathway [121-






TABLE 1.  Growth regulators of endochondral ossification. 
Gene Function Reference 
Bone Morphongenetic Proteins (BMPs) C, O [124] 
c-Fos O [125, 126] 
C-type Naturiuetic Peptide (CNP) C [127] 
Fibroblast Growth Factor Receptor 3 (FGFR3) G [98, 128] 
FGFs C [92, 95, 129] 
Growth Hormone(GH) G [96, 105, 130-132] 
Hedgehogs C,O [96, 105, 130] 
Matrix Metalloproteases (MMPs)* C,O,V [87, 133, 134] 
Nuclear factor of activated T-cells c1 (NFATc1) O [135] 
Nuclear Factor of kappa light chain (NF-κB) O [136] 
Parathyroid hormone (PTH) G [95, 96, 137] 
Parathyroid hormone related protein (PTHrP) G [138, 139] 
PU.1 O [140] 
Runt Related Transcription Factor 2 (Runx2) V,C,O [141] 
Runx3 C,O [142] 
Mothers Against DPP Homolog 1 (SMADs) C [143] 
Vascular endothelial growth factor (VEGF) V [144] 
C=chondrogenic, G=global growth, O=osteogenic, V=vascular   
D. The role of SOX9 in chondrocyte proliferation and hypertrophic 
differentiation in growth plate development.  
Sex reversal Y-related high-mobility group box protein (SOX9) is a 
transcription factor required for proper development of mesenchymal precursors into 
chondroblasts [90].  Knockout models indicate that SOX9 may prevent inappropriate 
apoptosis [145, 146].  Several studies have shown that SOX9 acts as a critical 
regulator of proliferation in chondroblasts [85, 121, 147].  In humans, loss of SOX9 
function causes campomelic dysplasia, a disease that results in dwarfism and lack of 
sexual maturity as well as premature death in some cases [148].  In proliferative 
chondroblasts, SOX9 promotes COL2 expression [145].  COL2 is the most abundant 
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protein in growing chondrocytes and is an important component of the ECM.  SOX9 
also appears to regulate effectors of the IHH and PTHrP pathways, which are 
responsible for proper chondrocyte development [145].  Other genes regulated by 
SOX9 alter ECM formation and potentially chondrocyte differentiation. These genes 
include: aggrecan, COL11, and Cdrap [149-151].  BMPs and noggin, a BMP 
antagonist, are known to differentially regulate SOX9 expression [152].  In addition, 
SOX9 regulates chondrocyte differentiation by controlling expression of SOX5 and 
SOX6 [145].  PRKG2 has been implicated as one kinase that regulates transition to 
the hypertrophic state by preventing SOX9 nuclear translocation [85].  In rats 
missing the cyclic guanine monophosphate (cGMP) binding domain of PRKG2, the 
systematic order of chondrocyte development was lost, presumably due to the 
inability of SOX9 to function properly [85].  SOX9 is a good example of a protein that 
needs to be expressed in the right place at the right time.  Various mutations in 
SOX9 also demonstrate the context specific function of genes in biology and the 
other possible complications that can occur in combination with skeletal disease. 
Forms of skeletal disease 
A.  Overview 
Skeletal growth and stability is vital to muscle function, protection of internal 
organs, maintenance of calcium[J14] stores, haematopoiesis in bone marrow, and 
self-confidence.  Fortunately, advances in modern medicine are beginning to 
elucidate the molecular pathogenesis of osteogenic diseases.  Modern medicine 
allows parents to supplement their children with growth hormone to offset short 
stature.  Seminal research in bone development was focused largely on nutritional 
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aspects of bone disease.  Rickets, vitamin D deficiency, was the first well-
documented bone disease for which a treatment was developed by Steenbock 
(1924).  Advances in the 1950s-1970s by Carlsson and DeLuca introduced the 
importance of Vitamin D in bone growth and stability [153, 154].  These discoveries 
drastically reduced the number of nutritional bone growth deficiencies 
worldwide[J15]. Current research is connecting genetic predispositions to nutritional 
bone diseases studied in the past.  Advances in transgenics and molecular biology 
techniques have allowed researchers to better understand early bone development.  
Exploration of developmental factors in bone growth is now the norm.  Future 
research will likely combine both disciplines to understand how genetic and 
environmental interactions effect bone growth[jk16]. 
          B.  Genetics of skeletal disease  
Genetic causes of bone disease have been difficult to deduce, because of 
complex inheritance or challenging phenotypic measurements.  However, transgenic 
mouse lines have been developed to investigate the deletion of single genes.  There 
is a vast array of skeletal diseases which suggest that substantial dissection of 
osteogenic developmental pathways will be required to find treatments to alleviate 
complications associated with skeletal diseases.  The most common form of 
dwarfism, achondroplasia, is estimated to affect between 1 in 20,000 and 1 in 
40,000 children born.  Unfortunately, few types of dwarfism have been characterized 
at the genetic level.  Complications associated with dwarfism cause life-long medical 
problems with varying levels of severity.  Complications range from hearing loss 
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[155] and obesity [156] to neurological disorders and shortened life expectancy 
[157].  
 Bone diseases come in many different forms. The most common form of 
skeletal disease is osteoporosis.  Osteoporosis is the loss of mineralization within 
the bone that leads to weakened bones that are more susceptible to breaks or 
fractures.  It is caused by the inability of bone to replace mineral in the bone during 
the remodeling process. Allelic variation in the LRP5 gene has been associated with 
high and low bone mass [158, 159].  Insufficient calcium is most often the cause for 
this disease.  A similar disease, osteomalacia, occurs if there is insufficient calcium 
and phosphate for mineralization of newly formed bone in the osteoid.  The 
symptomology of rickets is actually very similar. However, rickets tends to occur in 
immature bone whereas osteomalacia can occur at any time during life.  Both 
disorders are caused by vitamin D deficiency, often as a result of insufficient 
exposure to sunlight; however, occasionally kidney and liver disorders can cause 
these diseases.  Mutations within the DMP1 gene have been discovered that greatly 
alter an individuals susceptibility to rickets and osteomalacia [160].  Pagets 
disease[J17] is a bone remodeling disorder in which too much bone mineral turnover 
occurs, because osteoclasts become overactive.  Complications can include 
increased bone fracture and increased rate of osteosarcoma.  Osteoarthritis afflicts 
millions of people world wide, causing decreased mobility and quality of life.   A 
number of genetic risk factors have been identified, including mutations in COL2 
[161].  Osteosarcoma, bone cancer, is perhaps one of the most difficult types of 
skeletal disease and cancers to treat.  There are many causes of osteosarcoma, 
 33
both genetic and environmental, making it a particularly difficult disease to treat and 
one worthy of considerable research.   
C.  Skeletal malformations 
 Skeletal malformations are caused by genetic disorders with varying levels of 
severity. Osteogenesis imperfecta and Ehlers-Danlos syndrome are well-
characterized diseases caused by mutations in the type I collagen (alpha-1) (COL1) 
gene, which lead to brittle bones and often death of newborns shortly after birth 
[162].  Without functional collagens in bone, it becomes an easily breakable 
substance.  Collagen in bone acts much like rebar in concrete roads, giving it a 
rigid, yet flexible structure.  Other diseases, such as Fibrodysplasia Ossificans 
Progressiva (FOP), result in overgrowth of the skeletal structure.  FOP is a 
devastating disease that results in cartilaginous and soft tissue transformation into 
bone.  Patients with OP literally turn into a large rigid skeleton with little ability to 
move or live a normal life.  Recently, a mutation in ACVR1 was discovered that is 
believed to cause this rare autosomal dominant condition [163].  Additional classes 
of skeletal malformations relevant to growth plate development include: 
spondyloepiphyseal dysplasia congenita (SED) hypochondrogenesis, 
achondrogenesis type II, Kniest dysplasia are all caused by a variety of mutations in 
COL2 [162, 164].  Mutations in COL2 have also been reported to cause Stickler 
syndrome [165].  Leri-Weill dyschondrosteosis, caused by haploinsufficiency of 
SHOX gene, and Langer mesomelic dysplasia, recessive version of SHOX 
mutation, are particularly intriguing skeletal malformations as they control of 
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stacking of chrondrocytes and chondrocyte maturation through hypertrophy [166, 
167].[J18] 
A host of skeletal patterning defects exist that can alter how limbs form and 
the overall structure of the axial skeleton.  Two excellent reviews of these disorders 
are provided [168, 169].  Discovery of the molecular causes of these diseases are 
critical to understanding the molecular mechanisms behind their pathology and for 
the development of treatments.  With the multitude of sub-classes of these skeletal 
diseases, considerable time will be needed to determine why each of these skeletal 
diseases occur.  A wide range of chondrodysplasias have been characterized at the 
phenotypic level.  The term chondrodysplasia really acts a catch all category that 
encompasses nearly all forms of skeletal malformations involving the process of 
endochondral ossification.  The next section will provide an overview of the various 
classes of chondrodysplasia.  Because of the vast number of diseases, it is critical 
to be able to differentiate the skeletal diseases when studying their mode of 
inheritance. 
Different forms of chondrodysplasia (dwarfism)-osteochondrodysplastic 
growth-plate defects 
Forms of dwarfism can be broken down into two general classes, 
proportionate and disproportionate dwarfism.  Proportionate dwarfisms result in 
completely miniaturized growth of all bones in the body, and are caused by incorrect 
function of global growth regulators, such as GH, PTH/PThlP.  Global regulators of 
growth such as the growth hormone (GH) pathway components, parathyroid 
hormone (PTH) and parathyroid hormone like protein (PTHlP), and fibroblast growth 
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factor receptor 3 (FGFR3) were among the first genes found to contain mutations 
responsible for human dwarfism [97,131,137,138,216,217].  Disproportionate 
dwarfisms are characterized by shorted vertebrae and/or appendages with normal 
body trunk and skull size.  There are many forms of disproportionate dwarfism, but a 
few major classes bear mentioning.  Diastriohic dysplasia is a form of 
disproportionate dwarfism caused by a mutation in a sulfate transporter gene, called 
DTDST.  This disease leads to poor cross linking of collagens within joints and 
growth plates, and has a number of side effects, including respiratory problems. 
Pseudoachondroplasia is caused by a mutation in the COMP gene.  It is nearly 
indistinguishable from achondroplasia, demonstrating the difficulty in differentiating 
some dwarfism subclasses.  Spondylo-epiphyseal dysplasia (SED) also results in 
cleft pallet and hip-joint deformities, showing the range of problems that can coexist 
with dwarfism.  Mutations in PTHR demonstrate how multiple mutations in the same 
gene can lead to different pathological problems.  Jansens metaphyseal 
chondrodysplasia is caused by a dominant mutation in PTHR, leading to activation 
of receptor and increased bone turnover.  Conversely, Blomstrands 
chondrodysplasia74 is caused by a recessive PTHR receptor loss of function 
mutation that causes premature bone aging and early death.   There are many 
dwarfism subclasses, and only a few have been characterized at the molecular level. 
More than 200 types of dwarfism have been diagnosed with varying severities, and 
complications that decrease the quality of life for patients.  Theoretically, this would 
suggest that hundreds of genes could have mutations capable of causing dwarfism 
with multiple mutations within a gene causing different skeletal disease phenotypes 
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(e.g. SHOX, PTHR, FGFR3 mutations).  It is hard to postulate whether each of these 
subclass of chondrodysplasia represents a unique form of dwarfism, but it is clear 
that many forms of dwarfism occur in nature. 
 Achondroplasia 
Achondroplasia is the most common form of inherited skeletal disease [170].  
Achondroplasia is a subclass of dwarfism caused by disproportionate growth of the 
long bones as compared to the body trunk.  In humans, the disease is characterized 
by macrocephy, midface hypoplasia, rhizomelic shortening of the limbs and caudad 
narrowing of the lumbar interpediculate space [91, 156, 171].  Among the various 
concerns associated with achondroplasia, physicians closely monitor pregnancies 
for problems as mortality is higher for achondroplastic infants.  In addition, 
considerable monitoring is done for cervico-medullary compression which can lead 
to fatal neurological conditions.  Many forms of achondroplasia have been 
characterized, but few have been explained at the molecular level.  In humans, 
achondroplasia is a dominant genetic disease caused by mutations in the FGFR3 
gene.  Many mutations have been identified, with varying disease etiologies.  In 
sheep, a mutation was discovered in FGFR3 that leads to excessive skeletal growth 
in the form of lengthened limbs called spider syndrome [172].  In humans, an allelic 
series of FGFR3 mutations can cause SADDAN syndrome, hypochondroplasia, 
craniosynostosis syndrome, and a host of other unique achondroplasias.  In all, 14 
different allelic variants of FGFR3 occur naturally, with all except two mutations 
causing a form of chondrodysplasia [173].  Additional components in the MAPK 
signaling pathway may also be responsible for dwarfism phenotypes.  Cyclic- 
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guanidine monophosphate (cGMP) dependant, type II, protein kinase (PRKG2) is a 
gene known to contain mutations that cause dwarfism that may interact with FGFR3 
signaling [85, 101]. 
CURRENT KNOWLEDGE OF THE PROPERTIES AND FUNCTIONS 
OF PRKG2 
Overview 
There are a variety of cGMP regulated genes, including phosphodiesterases 
(PDEs), cyclic nucleotide gated cation channels, and kinases.  Within the cGMP 
regulated kinase family, there are two genes, with three splice isoforms.  For the 
most part, these mRNA isoforms do not overlap in their location of expression.  It is 
believed that the mRNA splice isoforms location [J19]is closely tied to their function 
[174]. Based on the similarities in gene sequence, it is likely that these genes are 
paralogues.  The two genes, PRKG1 and PRKG2, appear to have similar functions 
in ion transport, and are co-localized in a few tissues such as growth plate, kidney, 
brain[J20] and lung [175-177].   The regulation of the proteins created by the cGMP 
regulated family of genes appears to be regulated in a very similar way.  Nitric Oxide 
(NO), cGMP, and guanylyl cyclases (GCs) are universal in regulation of all cGMP 
regulated family members [174, 178].  In some cases, tissue specific regulators have 
been discovered which would allow for differentiation between the isoforms.  Focus 
herein will be on the kinases, as PRKG2 plays an important role in growth plate 
development.  Nomenclature for PRKG2 is as follows:  PKG can be either PRKG1 or 
PRKG2, PRKG2 is the coding gene, and PRKG2 is the protein.    
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PRKG1 
 The gene PRKG1 is a paralogue of PRKG2 and is expressed in two splice 
isoforms, PRKG1α and PRKG1β.   The PRKG1 and PRKG2 mRNA and protein 
sequences show 70% similarity in their catalytic domain [179].   It is currently 
unknown weather there is cross-over between the substrates of PRKG1 and 
PRKG2.  However, it is known that PRKG1 and PRKG2 are co-expressed in some 
tissues, such as the growth plate.  In fact, new research indicates[J21] that PRKG1 
may signal IL-6 in osteoblasts to regulate their development [180].  However, the 
role of PRKG1 in the growth plate has not been determined.  PRKG1 research has 
centered on regulation of NO and cGMP in the heart, brain and smooth muscle.  The 
PRKG1 protein is expressed[J22] in the cytosol of smooth muscle, platelets, brain, 
kidney, cardiac muscle, vascular endothelium, granulocytes, chondrocytes, 
osteoclasts, and lung [174].  Hoffman et al. and Pilz and Broderick have published 
excellent reviews of PRKG1 function with additional details about its function [174, 
181].  
PRKG2 
 Considerably less is known about PRKG2 and its role in the body than is 
known about its close relative PRKG1.  Unlike PRKG1, the PRKG2 protein is 
membrane bound and is not functional if it is located in the cytoplasm [182].   An N-
terminal myristoylation site is therefore required for normal PRKG2 function [183].  
The full-length human PRKG2 protein is 762AA long and weighs 87kDa [179].  The 
gene is comprised of 19 exons, while the protein has 3 functionally distinct domains.  
These domains include an N-terminal regulatory domain, which includes 
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dimerization and auto inhibitory regions, a C-terminal catalytic (kinase) domain, and 
two cGMP binding domains that have different affinities for cGMP.  Although the 
protein has not been crystallized, its functional domains have been well described 
[178].  There are two known splice variants of PRKG2, one that is translated into a 
functional protein and the other that results in a dominant negative isoform, which 
lead to an inactive dimerized protein complex.   
The gene is expressed in a myriad of tissues, including: adrenal cortex (zona 
glomerulosa cells), brain, eye (multiple cell types), fibroblasts, gallbladder (epithelial 
cells), intestines (all except distal colon), kidney, lung (Clara cells), pancreas, 
prostate (stromal cells), and salivary glands [84, 184-194].   Expression in the brain 
is extensive in that it is expressed in the amygdale, brainstem nuclei, cerebral 
cortex, hypothalamus, medial septum, olfactory bulb, septum, striatum, thalamus 
and numerous other areas; see the Allan brain map at http://www.brain-map.org/ 
[195].  It has been suggested that it may also be expressed in the glomerulosa and 
cumulus oocyte complex cells [J23]of[jk24] a follicle, ladig cells of the testis, and stem 
cells [196, 197]. 
Animal models for understanding PRKG2 function 
 Two mammalian animal models exist currently for the dissection of PRKG2 
function.  Some limited work has been done in lower organisms including C. elegans 
(egl-4) and the drosophia melanogaster (dg1) where homologues of the gene have 
been discovered [198, 199]. Pfeifer et al. (1996) created a knockout mouse that 
inactivated the PRKG2 gene.  Their results indicated that PRKG2 is a major 
regulator of interstial fluid movement in the small intestine.  To their surprise, these 
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mice also exhibited dwarfism, with shortening of the long bones and no change in 
bone length of bones derived from intramembranous ossification.  Additional work 
has been done to determine the function of PRKG2 in the brain, specifically in the 
area of circadian rhythm [200].  A second model was discovered when a research 
group in Japan identified a large, naturally occurring deletion in PRKG2 causes 
dwarfism in the Kmi mini rat [85].  Additional studies determined that PRKG2 is a 
regulator of SOX9 transcription, acting like a switch to change chrondrocytes from a 
proliferative to hypertrophic growth state.  Studies in the Kmi rat provided a 
mechanism that suggested PRKG2 couples the proliferative and hypertrophic growth 
states [201]. 
Activation and Regulation of PRKG2 
 PRKG2 appears to operate in a lumenocrine fashion to regulate electrolyte 
and water transport particularly in kidney, lung, and pancreas.  As a membrane 
bound protein, PRKG2 is often localized close to ion transporters such as the CFTR.  
Regulation of other ion transporters include: NHE3, TRPV5/ECAC1 [183, 202, 203].  
Activation of PRKG2 at the global level seems to funnel through two major 
regulatory systems with differences in regulation likely existing at the tissue level.  In 
epithelial tissue, the heat-stable enterotoxin receptor (STa) of E. coli signals through 
the guanylyl cyclase c(GC-C) resulting in cGMP release and subsequent activation 
of PRKG2.  In a second major pathway, Nitric Oxide (NO) signals both GC-S or 
naturiuetic peptide coupled GCs (GC-A and GC-B), again, resulting in a cascade of 
cGMP and PRKG2 activation. This signaling pathway appears to be important in 
both the brain (ANP coupled GC) and growth plate (CNP coupled GC) [127].  In 
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each case, the GCs are often co-localized with PRKG2.  Without the presence of 
cGMP, the PRKG2 protein is inactive.   
The PRKG2 protein appears to regulate itself by autophosphorylation leading 
to a constitutively active protein.  The level of autophosphorylation creates a kind of 
memory in the protein in response to the level of cGMP that is present in the cell 
[204].  With increased levels of cGMP, the protein becomes less responsive to 
cGMP stimulation, and less likely to phosphorylate a substrate [205, 206].  The 
phosphorylation sites appear to correspond with kinase activity, indicating they may 
play an important role in the regulation of PRKG2 function.  Autophosphorylation 
alters the phosphorylation status of PRKG2 and whether the slow or fast response 
elements respond quickly or more slowly to cGMP.   A number of substrates have 
been identified, including: CFTR, STaR, SOX9, and PTPS [85, 186, 207, 208].   
Role of PRKG2 in the growth plate 
 PRKG2 acts as a molecular switch for the transition from the proliferative to 
hypertrophic state in osteocytes in the rat [85]. Mutations in PRKG2 cause disruption 
of endochondral ossification and achondroplasia. In the absence of PRKG2, 
Chikuda et al., (2004) clearly demonstrate that markers of proliferation, p57kip2 and 
COL2, and hypertrophy, IHH and COL10, are inappropriately expressed in the rat 
PRKG2 mutant.  Both studies show that PRKG2 kinase function is lost in their 
respective mutants and that normal phenotype can be rescued in vivo [84] and ex 
vivo, in cell culture [85].  The expression of PRKG2 in the growth plate is highly 
dependant on the differentiation state of chrondrocytes.  PRKG2 appears to be 
expressed in proliferative chrondrocytes, whereas hypertrophic chrondrocytes would 
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appear to have predominantly PRKG1 expression [101].  Some recent publications 
suggest that PRKG2 may tie into the PTH or PTHlP pathways [209].  It was 
suggested in a recent publication that PRKG2 is downstream of CNP based on 
analysis of CNP knockouts and CNP by PRKG2 knockout crosses [127].  Studies 
investigating the role of CNP have discovered a like to p38MAPK [101, 210].  It is 
possible that p38MAPK could be an intermediate signal transducer for PRKG2.  
Despite these important discoveries, little is known about PRKG2s upstream 
regulators, how it acts as a global regulator, or its functional role in bone beyond the 
regulation of SOX9.  To date, a human achondroplasia caused by PRKG2 mutation 
has not been discovered; however, one human dwarfism does map to this locus 
[211]. 
Additional Roles of PRKG2 throughout the body 
 Beyond its critical role in endochondral ossification, PRKG2 is suggested to 
have a wide range of functions throughout the body.  Considerable research has 
shown that PRKG2 is a key regulator of ion transport through the cystic fibrosis 
transmembrane conductance receptor (CFTR) [84, 192, 208, 212, 213].  Even 
though much of the end function of PRKG2 is unknown, there is a common theme to 
PRKG2 function, electrolyte and water transport.  Throughout much of the body, 
PRKG2 is co-localized with its substrates that regulate ion transport.   The best 
characterized function of PRKG2 in specific tissues has been in the intestines and 
kidneys.  In the intestines, PRKG2 knockout mice have been shown incapable of 
responding to the STa toxin of E. coli that would normally cause diarrhea.  The 
expression is mostly in the tip of the villus of the jejunum along the brush boarder 
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with some expression in the basolateral membrane.  Interestingly, in cell culture, the 
expression of PRKG2 appears to be lost overtime with passaging of cells [183].  In 
the kidney, expression is throughout, in the connecting tubules, cortical collecting 
ducts, the thin loop of Henle, and to a lesser extent in the proximal tubules and is co-
localized with GC-C.  It is clearly expressed in the juxtaglomerular cells.  Research 
indicates that PRKG2 responds to salt and angiotenesin levels resulting in changes 
in PRKG2 expression [212].     
Some additional characterization has been performed in the brain and 
pancreas.  Recent localization of PRKG2 in the brain as determined by the Allan 
brain-mapping project indicates that PRKG2 is expressed abundantly through out 
many regions of the brain.  Connections between behavior and circadian rythemicity 
have been discovered.  Behavioral studies suggest that PRKG2 may be involved in 
regulating aggressive behavior as well traits related to alcoholism.  These behavioral 
responses are consistent with PRKG2s expression in the amygdala which is known 
to harbor control of emotional and behavioral responses [207].  In studies involving 
the knockout mouse, PRKG2 knockouts favored alcohol consumption to water and 
spent less time intoxicated as indicated by righting experiments [214].  In circadian 
rythemicicty, it was determined that PRKG2 is required for clock resetting.  In fact 
mPer1 and mPer2 gene expression is regulated by found to be substrates of PRKG2 
[200].    In the pancreas, PRKG2 appears to play a role in electrolyte transport via 
CFTR [191].   
In the lung, relatively little is known about the role of PRKG2, except that it 
directly regulates CFTR in the Clara cells deep within airways.  It has been 
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suggested that this regulation of CFTR is likely subject to cross talk with PKA, and 
may play a pivotal role in better understanding CFTR regulation [178, 192].  
Research related to CFTR in the lung is obviously of high importance due to CFTRs 
role in Cystic fibrosis.  Improved characterization of PRKG2 could help in the 
development of therapeutics for this very common and devastating genetic disease.   
Potential uses for PRKG2 in therapeutic treatments 
 Several roles for PRKG2 have been suggested by medical researchers as a 
therapeutic for disease.  Studies by Pfeifer et al. (1996) clearly indicate that PRKG2 
is vital for proper bone healing after injury, especially in the growth plate.  The ability 
to enhance PRKG2 expression in bone fractures, especially in cases of green break 
may be invaluable in speeding and improving bone healing following injury [85].  It 
has been suggested that PRKG2 could be over-expressed in patients suffering from 
achondroplasia to compensate for mutated FGFR3 [127, 210].  Since PRKG2 
appears to control cell cycle at the switch from proliferative to hypertrophic growth, it 
has also been suggested that it may be possible to use PRKG2 to treat 
osteosarcoma [215].  Since PRKG2 is a regulator of ion transport, it may play a 
critical role in Calcium homeostasis.  PRKG2 is expressed in kidney, bone, small 
intestine, all places where calcium can be shuttled in or out of the body.  Perhaps, 
targeted usage of PRKG2 could help increase calcium usage in individuals suffering 
from osteoporosis and other calcium metabolic diseases.  The potential to use 
PRKG2 as a therapeutic for treatment of Cystic fibrosis and prostate and colorectal 
cancers has also been suggested, but will require considerable research to 
determine the relevance of PRKG2 in these treatments.  In any of these cases, 
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many additional studies will be needed to determine effective treatments that are 
feasible to make the jump from theory to use in the medical field.  
ABBREVIATIONS USED IN LITERATURE REVIEW 
AA = amino acid 
AIL = advanced intercross line 
BEAP = BLAST Extension and Alignment Program 
BMU = bone metabolic unit 
Bps (kbps/Mbps) = base pairs (k=kilo, and M=Mega) 
BTA= Bos taurus autosome 
cM = centiMorgans 
ES = Elston-Stewart algorithm 
F2 = F2 population design (F2= 2nd filial generation) 
FOP = Fibrodysplasia Ossificans Progressiva  





LOD=likelihood of odds 




RIL=recombinant inbred lines 
SED=spondylo-epiphyseal dysplasia congenita 
SNP=single nucleotide polymorphism 
TDT=transmission disequilibrium test 
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ABSTRACT 
 In the 1950s and 60s, dwarfism was the major genetic defect in beef cattle in 
the United States.  Aggressive culling and sire testing were used to minimize the 
prevalence of dwarfism.  However, neither of these two practices can eliminate a 
recessive genetic defect.  We assembled a four generation pedigree that consisted 
of 26 animals to identify the mutation that underlies dwarfism in American Angus 
cattle. An adaptation of the Elston-Steward algorithm was used to overcome the 
small pedigree size and missing genotypes for individuals without DNA samples.  
Microsatellite markers were used to localize and fine-map the mutation to a 0.8 cM 
region on Bos taurus autosome (BTA) 6, which was flanked by the microsatellite 
markers AFR227 and BM4311.    Four positional candidate genes were located 
within or 1 cM from this critical region.  Sequence analysis of these candidate genes 
revealed a nonsense mutation ,R678Z, in exon 15 of cGMP-dependant, type II, 
 65
protein kinase (PRKG2). This C/T transition introduced a stop codon that truncated 
85 C-terminal amino acids of PRKG2.  A large portion of the kinase domain was 
included in this truncation.  Of the 76 mutations discovered in this region, this 
mutation was the only one that was 100% concordant with affected and carrier 
individuals within our pedigree. We evaluated the ability of wildtype or R678Z 
PRKG2 to regulate collagen (COL2) expression in cell culture.  Real-time PCR 
results confirmed that COL2 is over-expressed in cells that over-expressed the 
R678Z PRKG2 mutation as compared to wildtype PRKG2. Furthermore, expression 
of COL2 mRNA expression was increased in dwarf cattle compared to normal cattle.  
These experiments indicate that the exon 15 nonsense mutation is functional, 
resulting in a loss of PRKG2 regulation of COL2 and collagen 10 (COL10) mRNA 
expression.  Therefore, we present the PRKG2 exon 15 mutation as a causative 
mutation for dwarfism in American Angus cattle. 
INTRODUCTION 
Angus dwarfism was widely observed between the 1940s and 1960s [1].  At 
the same time, Hereford breeders were struggling with dwarfism as well.  During this 
era, dwarfism was very prevalent, making it one of the greatest problems to face the 
beef cattle industry.  Even President Eisenhower showed great interest in the 
disease as dwarf calves were born on his ranch.  Over the past 60 plus years, 
dwarfism has cost beef producers millions of dollars.  Dwarfism was thought to have 
been eliminated by the 1970s, until six dwarf calves were discovered on several 
ranches across the U.S. in the spring of 2002.  Dwarf animals represent an 
economic loss, because of slow growth and lack of market value.  Cattle breeders 
 66
with suspect dwarfism carriers have lost their livelihood due to the connotations 
associated with the damaging history of dwarfism in the beef industry. Today, there 
is no good estimate of the number of affected individuals in the U.S.  Rumors 
suggest that dwarf calves are often not reported, and are removed from herds at 
birth to prevent negative publicity for the cattle breeder.   Breeders have attempted 
to remove dwarfism historically by using test matings or removing parents known to 
produce affected offspring [1].  These methods were extremely costly and did not 
remove all of the carrier animals.  Development of a genetic test to eliminate 
dwarfism is needed to solve these problems.  A definitive test will allow producers to 
improve profitability and conserve genetically superior carrier animals with desirable 
genetic backgrounds in Angus.   
 A multitude of dwarfism phenotypes occur in nature.  Dwarfism occurs in 
many species and several animal models have been discovered. Notably, models in 
the mouse have been used to understand the implications of mutations within the 
fibroblast growth factor receptor 3 (FGFR3) gene.  In humans, achondroplasia is 
caused by a dominant mutation in the FGFR3 [2].   In cattle, some forms of dwarfism 
have been characterized at the molecular level, i.e. Dexter and Japanese Brown 
cattle [3, 4].  Angus dwarfism is characterized as a form of achondroplasia.  Affected 
individuals have diminished endochondral ossification of growth plates, protrusions 
of the alar wing of the basisphenoid bone into the cranial cavity, abnormalities of the 
ventral vertebral bodies and curvature of the vertebral processes [5]. A mode of 
inheritance for Angus dwarfism has not been formally tested.  Based on the 
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appearance of dwarf calves, only in very specific matings, it was hypothesized that 
Angus dwarfism followed a recessive pattern of inheritance.    
Our group previously investigated the possibility that Angus dwarfism was 
caused by the same mutations in the LIMBIN gene that lead to a recessively 
inherited dwarfism in Japanese brown cattle.  Analysis of the two mutations in 
LIMBIN indicated that Angus dwarf calves were wildtype for both mutations [5].  In 
addition, we wanted to determine if Angus dwarfism was caused by the same 
mutations as observed in Dexter dwarfism.  All Angus dwarf samples were wildtype 
for the Dexter dwarfism markers (unpublished data), indicating that Angus dwarfism 
is most likely caused by a novel mutation.  
 Herein, we describe the fine-mapping and analysis of positional candidate 
genes for dwarfism in American Angus cattle.  DNA was available for only 23 of 26 
individuals in our pedigree.  Therefore, we used a unique adaptation of the Elston-
Steward algorithm to refine the position of the disease locus.  We present strong 
evidence that a nonsense mutation within the kinase domain of cGMP-dependant, 
type II, protein kinase (PRKG2) is the causative mutation for Angus dwarfism based 
on linkage-mapping, protein changes, expression data, a breeding experiment, and 
comparison with existing mutant rodent models. 
MATERIALS AND METHODS 
Population 
We constructed a four generation pedigree to determine the relationship 
between six individuals diagnosed as dwarves (Figure 1).  This pedigree consists of 
26 individuals that are related to two founders.  Carrier and dwarf phenotypes were 
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determined based on production of dwarf calves and diagnosis of dwarfism by 
veterinarians.  Of the 26 individuals, DNA was available for only 23 individuals.   
General lab techniques 
DNA was extracted from several tissues.  DNA was collected from whole 
blood, semen (Wizard DNA kit, Promega; Madison, WI), and blood on Whatman 
FTA cards (Whatman; Florham Park, NJ).  PCR was performed as described (Table 
1).  RNA was isolated by Trizol method (Invitrogen; Carlsbad, CA). 
Preliminary linkage analysis 
Chromosomes were prioritized for linkage analysis based on number of 
candidate genes known to cause dwarfism in humans or cattle on each 
chromosome. These chromosomes included BTA 1, 6, 14, and 19.  Ten 
microsatellite markers were genotyped on each chromosome and used for linkage 
analysis to provide a coarse position for the mutation. An adaptation of the Elston-
Steward methodology was used to perform linkage-mapping, described in detail 
below. This method allowed us to accommodate missing genotypes by summing 
over all genotype combinations during the likelihood calculation.  Based on these 
preliminary results, an additional 19 microsatellite markers were genotyped within 
and surrounding the critical region containing the highest LOD score.   Marker 
positions were obtained from USDA-MARC at 
http://www.marc.usda.gov/genome/genome.html [6].  Missing genotypes were 
accommodated in a pedigree with loops, common ancestors, using the method of 
Fernandez et al., [7, 8].  The linkage-mapping program was developed by R. Totir 
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and R. Fernando (unpublished data, L.R. Totir and R.L. Fernando).  It is available 
upon request.   
Statistical analysis-Elston Stewart methodology 
We used an extension of the Elston-Stewart algorithm in a model-based 
linkage analysis to map the genomic location most likely to contain the dwarfism 
locus [9, 10].  The method was modified to make it more computational feasible 
when pedigrees contain multiple loops to common ancestors. The implementation is 
described in the following citations [7, 8,10]. The implementation of linkage-mapping 
has been previously described [11]. The model for linkage-mapping assumes the 
disease allele follows a recessive pattern of inheritance that is present at a low 
frequency in the Angus population (Figure 3). Briefly, likelihood ratios were 
calculated for each marker interval assuming: 1) the dwarf mutation is at the center 
of this interval (L1), and 2) the dwarf mutation is on another chromosome (L2).  The 
log base 10 of this likelihood ratio (L1/L2) resulted in the LOD score.  Likelihood (L) 
can be expressed as 
 
 
where Pr(y) is a vector of dwarfism phenotypes, and Pr(G ) is a vector of genotypes 
at the markers flanking the interval and the dwarf mutation. A LOD score greater 
than 3 was deemed significant.  We used multiple disease allele frequencies in the 
model for the founder population to determine the influence of disease allele 




Matings and data generated from a breeding experiment 
Affected and unaffected full-sib calves were produced using embryo transfer.  
Two cows, mother (carrier) and daughter (dwarf), were mated to a bull known to be 
a carrier of dwarfism. There were more than 20 embryos produced for implantation 
into surrogate mothers.  Only 6 embryos survived to full term. The 6 calves were 
raised under the guidelines of the Iowa State University committee on animal care 
protocols.  These six calves were within the normal size range for newborn Angus 
calves and not distinguishable as dwarves at birth.  A DNA sample was collected 
from each calf and tested blindly to determine the genotype for the PRKG2 R678Z 
marker.  Calves were weighed and height and bone measurements were taken 
monthly to approximate lengths for the head, femur, metacarpal, metatarsal, tibia, 
and spine.  In addition, circumferences were measured for head, chest, metacarpal, 
knee and pastern. All measurements were performed in triplicate to reduce 
measurement error.  At approximately weaning age, the calves were sacrificed to 
collect tissues for functional analysis of the PRKG2 R678Z mutation and histological 
study.  Growth plate cartilage was collected from the tibia of each individual.  Length 
measurements were taken for the femur, head, tibia, fused ulna/ radius, metacarpal, 
and metatarsal. 
Statistical analysis of long bone length 
Analysis of long bones and measurements from the six calves produced in 
the breeding experiment, described above, using Proc GLM of SAS (SAS Institute; 
Cary, NC). For consistency and to avoid over-fitting of the model, each model was 
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fitted with the same factors, regardless of the independent variable (bone length).  
For long bone lengths, the model was 
yij = gi + eij, 
where gi = dwarfism genotype (yes or no), and e is the random error term.  For live 
measurements (spine and height lengths) the model was 
yijkl = gi +sj + Grk + eijkl , 
where s = sex, and Gr = birth group (encompassing age, dam, and common 
environment.)   
Bioinformatics/ sequence retrieval 
Linkage and human/ bovine radiation hybrid map comparisons allowed us to 
determine the gene content within the critical region.  We identified the segment 
between 79.18 and 84.73 Mbps in human as the most likely region to contain our 
mutation.  Radiation hybrid mapping data as well as sequence maps in human, rat 
and mouse indicated a highly conserved syntenic block.   We hypothesized that 
cattle would also retain this syntenic gene block.  Human genes contained within this 
gene block acted as the template to find the bovine orthologues/ homologues by 
BLAST analysis [12, 13].  The retrieved sequences were used to perform an in silico 
chromosome walk using a software we developed called BEAP to build contigs and 
predict bovine gene sequence.  The software is available upon request, and a web-
based version of the software is in development.   All template sequences were 
retrieved at http://www.ensembl.org/index.html [14], and  
http://www.genome.ucsc.edu/ [15].  Primers were designed from these sequences 
using Primer3 at http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi [16]. 
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Sequence analysis of positional candidate genes and genotyping  
We performed PCR with primers that flanked each exon of the four candidate 
genes that were investigated.  Primer sequences are given in Table 1.  Genotypes 
were obtained by RFLP and single-base extension using SNaPshot chemistry (ABI; 
Foster City, CA). Products were analyzed on an ABI-3100 and results were analyzed 
using Genescan® software (ABI; Foster City, CA). The SNaPshot reaction was 
performed as described by the manufacturer.  Primers used for Snapshot are 
provided in Table 2.  RFLP assays are described in Table 3. 
Cloning, cell culture, transfection, real-time PCR and analysis 
 We cloned the full-length bovine PRKG2 cDNA into pGEM T-easy vector 
(Promega; Madison, WI).  The insert was then shuttled to the pcDNA3 expression 
vector (Invitrogen; Carlsbad, CA) by digestion with Xba I and Apa I restriction 
enzymes (New England Biolabs; Ipswich, MA) followed by ligation with T4 ligase 
(Promega; Madison, WI).  This bovine PRKG2 vector was then mutated to contain 
the PRKG2 exon 15 R678Z mutation by site-directed mutagenesis using the 
QuickChange II kit (Stratagene; La Jolla, CA). The resulting vectors were verified 
using RFLP and DNA sequence analysis.  Cell culture was performed as described 
by Chikuda et al. [9].  Briefly, HUH7 cells were transiently transfected and treated 
with 8Br-cGMP (Sigma; St. Louis, MO) 4 hours post transfection.  Cells were 
harvested 72 hours post transfection and total RNA was isolated with the Qiagen 
RNeasy kit (Qiagen; Valencia, CA ) according to manufacturers protocol.  RNA was 
reverse transcribed with Superscript III (Invitrogen; Carlsbad, CA) for downstream 
amplification of cDNA in a real-time PCR reaction that used Syber green chemistry 
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(BioRad; Hercules, CA). COL2 mRNA levels were evaluated using the primers F- 
CTT AGG CCC GAG AGA GAA GG, R- ACT CAG GGT GGC AGA GTT TC and the 
house keeping gene GAPDH: F- TGA TGA CAT CAA GAA GGT GGT GAA G, R- 
TCC TTG GAG GCC ATG TAG GCC AT for transfection data.  Expression levels in 
cattle were analyzed using the same COL2 primers, COL10 primers F- AAT CTG 
AAA TGC AAG GTG CT, R- AAG ACT CAA ATA GTC ATT AAA GCA AA, and β-
actin as the house keeping gene, F- AA GGA CTC GTA CGT GGG GGA TGA, R- 
AA GGA CTC GTA CGT GGG GGA TGA.  Real-time PCR expression data were 
analyzed first using MyiQ software to normalize the data (BioRad; Hercules, CA).  
The normalized expression data was then statistically analyzed using the natural log 
of the starting quantity of cDNA for transfection data and the ddCt method [17] for 
cattle expression data in Proc GLM of SAS (SAS Institute; Cary, NC).  The model 
used to analyze used to analyze the transfection data was  
yijkl = pi +tij+dk + eijkl , 
where y= ln starting value of mRNA, p = real-time plate replicate, t = treatment 1  4 
as described in results, d = experiment date, and e = error.  The model used to 
analyze the expression data from cattle growth plate was 
yijkl = pi +gij + eijk , 
where y= ddCT , target gene (either COL2 or COL10)  housekeeping gene (β-
actin), for the dwarf subtracted from the target gene housekeeping gene, for a 




We detected a significant LOD score of 7.34 on BTA6 between two 
microsatellite markers, AFR227 and BM4311 (Figure 2).  Based on this result, we 
focused on fine-mapping of BTA6.  We added an additional 19 microsatellite 
markers within or closely flanking the critical region to verify the position of the 
dwarfism locus.  Analysis of this data increased the size of the critical region from 
0.8 to 2.8cM, flanked by markers AFR227 and BMS511; however, the new critical 
region still encompassed the original region (Figure 3).  A secondary peak in LOD 
score appeared in this second analysis that was attributed to linkage disequilibrium 
with the true mutation and an over estimation of the number of affected individuals in 
the founder population.  When the allele frequency for the disease locus was 
decreased from 0.0001 to a more appropriate frequency, 0.00001, a reduced LOD 
score was observed between GBKCAS and CSN3 and no change in the LOD score 
between AFR227 and BMS511 (Figure 3). We also analyzed BTA6 using additional 
disease allele frequencies to see if the primary LOD score peak would reoccur.  In 
none of the other frequencies attempted, did the primary LOD score peak increase 
to a significant LOD score. Thus, the causal mutation mostly likely resided within the 
originally identified region flanked by AFR227 and BM4311.   
Identification and analysis of positional candidate genes 
 We used the human-bovine comparative radiation hybrid map 
(http://cagst.animal.uiuc.edu/RHmap2004/index.html) to identify positional candidate 
genes [18].  Human gene sequence was used to BLAST query bovine gene 
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sequence from the preliminary bovine genome draft.  Queried sequences were used 
as template for repetitive BLAST analysis to perform an in silico chromosome walk.  
We used CAP3 to assemble retrieved sequences into contigs. Perl scripts were 
used to tie these tasks together into a pipeline for retrieval of template sequences for 
primer design.  We identified 20 genes in cattle by BLAST analysis within or closely 
surrounding the critical region.  Of these genes, four candidates, bone 
morphogenetic protein 2 kinase (BMP2K), bone morphogenetic protein 3 (BMP3), 
fibroblast growth factor 5 (FGF5), and cGMP-dependant, type II, protein kinase 
(PRKG2) were identified based on their known function in bone development or 
relationship to genes known to be involved in bone development. 
Analysis of Positional candidate genes 
 We sequenced the exons and some flanking intron sequence of each 
candidate gene in a wildtype, dwarf carrier and dwarf animal.  Additionally, we 
sequenced one Hereford and one Brahman DNA sample as negative controls.  More 
than 75 SNP were detected.  We used the Brahman, Hereford, and unaffected 
Angus like control samples to determine if a given SNP followed the recessive 
pattern of inheritance for Angus dwarfism.  Few heterozygous SNPs were found 
were informative in BMP3 or FGF5 in for Angus, but many heterozygous informative 
SNPs were detected in BMP2K and PRKG2 (Table 4).  Seven SNPs were detected 
within exons; however, only one was non-synonymous.  This mutation resulted in a 
C to T transition [Nt2032 (C-T)] that caused a nonsense mutation in PRKG2.  This 
mutation caused a R678Z amino acid change.  The T mutation was homozygous in 
the dwarf, heterozygous in the carrier, and not present in the wildtype Angus, 
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Hereford, or Brahman (Figure 4).  Upon genotyping our pedigree, we found 100% 
concordance of the mutation with dwarf carrier and affected status.  We genotyped 
10 SNPs that surrounded the R678Z PRKG2 mutation and found a maximal LOD 
score of 8.66 for a marker interval including the nonsense mutation (Figure 5).  We 
genotyped additional breeds, including 8-10 random samples from Brahman, 
Hereford, Holstein, Limousin, and South Devon breeds as well as crossbred cattle 
composed of Maine Anjou, Charolais, Simmental and Angus (total number of 
samples genotyped was 54). However, we were unable to detect the R678Z PRKG2 
mutation in additional breeds to date indicating that this mutation maybe Angus 
specific. 
Predicted protein structure 
 To understand how the exon 15 nonsense mutation could alter PRKG2 
protein structure, we used the SwissModel homology protein modeling program to 
compare normal and dwarf PRKG2 [19, 20].  Since no crystallized structure of 
PRKG2 has been imaged, we used PRKG1 as a template for modeling due to high 
protein sequence similarity between these two paralogues.  Figure 6 displays the 
model of each protein and the changes that occur in the dwarf PRKG2 structure.  
These changes would appear to drastically change the protein structure of PRKG2.  
Additional protein modeling with PyMol [21] confirmed these results (data not 
shown).  A comparison of the primary amino acid sequence across seven species 
indicated that the mutation resides in a conserved block of 11 amino acid residues 
(Figure 7).  The [Nt2032 (C-T)] mutation changes an amino acid in dwarf calves and 
dwarf carriers, which leads to a premature stop codon instead of arginine (R678Z).  
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Since a stop codon was introduced in the sequence, a severe change in protein 
structure/function was expected.   
Functional analysis of the PRKG2 R678Z mutation in cell culture. 
 Based on previous studies in the rat [22], we designed a cell culture 
experiment to determine the functionality of the PRKG2 R678Z mutation found in 
dwarf individuals.  Human Hepatoma (HUH-7) cells were transiently transfected with 
one of four treatments: 1) wild-type bovine (bt) PRKG2 + human (h) SOX9; 2) R678Z 
btPRKG22 +hSOX9; 3) hSOX9 + empty vector; and 4) empty vector (Negative 
control).  PRKG2 is known to regulate SOX9 and down stream COL2 mRNA levels.  
PRKG2 down regulates COL2 by activation of SOX9 [22].  Therefore, we 
hypothesized that the truncated dwarf PRKG2 kinase domain would not be able to 
down regulate COL2.  Cells transfected with the R678Z btPRKG2 vector had a 38% 
increase in COL2 mRNA compared to cells transfected with wildtype btPRKG2 
(p<0.01) (Figure 8A).  There was no difference in COL2 levels between the control 
(empty vector only) and wildtype PRKG2 +hSOX9 treatment (P>0.70).  The hSOX9 
+ empty vector control treatment exhibited the same COL2 expression as the R678Z 
btPRKG2 +hSOX9 treatment (P>0.30) and increased COL2 expression compared to 
btPRKG2 + hSOX9 (p<0.001) and the empty vector alone (p<0.001) (Figure 8A). 
These results indicate that the R678Z PRKG2 mutation severely reduces the ability 
of PRKG2 to regulate SOX9 to levels comparable to a complete loss of function of 
PRKG2 (vector +hSOX9 treatment alone[jk31]).    
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Breeding trial results 
 To test the accuracy of the R678Z PRKG2 marker to predict dwarfism status, 
we genotyped the six calves produced in our breeding experiment within 2 weeks of 
birth to predict dwarf status using the R678Z PRKG2 marker.  Four calves were 
predicted to be dwarves (T/T) and 2 were predicted to be carriers (C/T). Animals 
declared dwarf by the R678Z PRKG2 marker had shorter metatarsals (reduced 
4.5cm; p<0.01), and fused ulna/radius (reduced 7.5cm; p<0.01) bones.  Although not 
significant, there were also trends toward significant differences between normal and 
dwarf metacarpals (reduced 2.75cm; p<0.09), femur (reduced 3.9 cm; p<0.17), and 
tibia (reduced 4.9 cm; p<0.11).  No significant differences were observed between 
these animals for head length, calvarium (skull) width, or bone circumference for 
each of the major long bones previously listed (p>0.25). Estimates of differences in 
stature and body length were also calculated for live dwarf and normal animals at 
approximately 210 days of age.  Differences in height of 15.8cm (p<0.0001) and 
20.7 cm of spine length (p<0.0001) were observed between animals declared 
normal versus those declared dwarf at birth (data not shown).    Based on height 
differences, gross differences in long bone length, and changes in vertebral length 
between dwarf and normal genotype classes, we have concluded that our test was 
100% accurate at predicting dwarf status in these six calves making the PRKG2 




Expression of COL2 and COL10 in bovine dwarf and normal growth plate 
cartilage 
 Expression of COL2 and COL10 was compared between four calves 
predicted to be dwarves and calves predicted to be normal at approximately seven 
months old.  Real-time PCR analysis confirmed a considerable increase in COL2 
mRNA in dwarf cattle compared to normal cattle (p<0.0001) (Figure 8B). Real-time 
PCR of COL10 indicated an increase in expression in dwarves compared to normal 
individuals (p=0.05)(Figure 8C).   Expression levels of both COL2  and COL10 were 
increased in dwarf cattle, indicating that dwarf cattle exhibit expression levels 
comparable to PRKG2 null animals. 
DISCUSSION 
 The use of the Elston-Steward algorithm was critical to our ability to find this 
mutation. This method allowed us to perform linkage-mapping using a small 
pedigree that contained three influential individuals that were deceased and no 
longer available for DNA sampling.  The ability to: 1) allow for all genotype 
possibilities simultaneously; 2) utilize individuals without genotype information; and 
3) determine likelihoods in a pedigree with complex loops allowed maximum 
information to be gleaned from the pedigree available. It is the combination of these 
three points that allow for such high accuracy in estimating the disease allele status 
and location.  These methods have been used previously, but this combination of 
adaptations has not been used previously to fine-map a causative mutation.  Without 
this method, it would likely not have been possible to find this mutation with such 
limited animal resources.  
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 PRKG2 is a logical candidate gene for dwarfism in Angus cattle.  Pfeifer et al. 
[23] created a knockout of PRKG2 in the mouse which resulted in dwarf mice.   It 
was noted that these mice exhibited an unorganized growth plate with abnormal 
stacking of chondrocytes.  More recently, Chikuda et al. [9] discovered a deletion in 
the coding region of PRKG2 that caused dwarfism in the KMI rat.  The loss of growth 
plate organization observed in these dwarf rats is very similar to what is observed in 
the Angus dwarf growth plate.  To explain the role of PRKG2 in growth plate 
organization, Chikuda examined the role of PRKG2 to regulate SOX9 in the growth 
plate.  The evidence presented convincingly demonstrated that PRKG2 regulates 
SOX9 via phosphorylation.  This is a key developmental checkpoint that allows 
proper transition of chondrocytes from a proliferative to hypertrophic growth phase.  
The existing knowledge of PRKG2 regulation of SOX9 provided a starting point to 
assess the functionality of the bovine R678Z PRKG2 mutation. 
SOX9 is a critical regulator of growth plate development. The PRKG2 
mutation in KMI rats abrogates phosphorylation of SOX9, which prevents nuclear 
translocation of SOX9 and the transition of collagen expression from Col2 
(proliferative) to Col10 (hypertrophic) within the growth plate.  These dwarf rats, 
PRKG2 mutants, show increased Col2 and decreased Col10 mRNA expression 
levels.  This is consistent with constitutive proliferative growth.  Functional changes 
in COL2 mRNA levels in Angus dwarf, PRKG2 mutants, are consistent with the 
PRKG2 mutant causing dwarfism in the rat.  These results indicate that the R678Z 
PRKG2 mutation was incapable of regulating COL2 mRNA expression.  Therefore, 
the transfection data indicates a functional change in PRKG2 protein of dwarf cattle 
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similar to that of a null PRKG2 individual.  Interestingly, the change in COL10 
expression in dwarf cattle was opposite of what was expected.  Dwarf cattle show 
increased expression of COL10, unlike the rat PRKG2 mutants.  This could be due 
to differences in tissue collection, small sample size or species differences.  
Alternatively, differences in COL10 expression could be explained, because bovine 
expression was measured in vivo compared to the measurements in the rat which 
were carried out in cell culture.  Regardless, these expression changes represent 
functional change in the PRKG2 protein.  It is likely this change results in impaired 
growth plate development. Since severe coding mutations cause dwarfism in both 
transgenic and naturally occurring dwarf animals, it is logical that a similar mutation 
in cattle would cause dwarfism as well. 
 The results from our breeding experiment show that the R678Z PRKG2 
mutation is accurate at predicting dwarfism status.  It provides evidence that we can 
predict dwarfism prior to appearance of the phenotype. The analysis of bone lengths 
is limited by the small sample size generated by embryo transfer. The differences 
detected do support the prediction of our marker genotypes and validate that both 
dwarf and normal animals were produced in our breeding trial.  Analysis of such 
small data is difficult because of the limited degrees of freedom available.  For 
purposes of consistency, all statistical models were the same. Special care was also 
taken to prevent over-parameterization of the models. This experiment does not 
prove causality, but in combination with our other results builds a strong argument 
that the R678Z PRKG2 mutation is an accurate marker and likely causative based 
on the body of research presented. 
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 The level of mutation and genetic variation of the Angus dwarf locus presents 
several intriguing questions.  Our method to find genomic sequence using a 
reiterative BLAST process ordered genes based on comparative genetic approaches 
similar to what was initially used by the bovine sequencing consortium.  Determining 
genomic sequence for cattle is now more feasible, because of the completion of the 
Bovine sequencing project.  However, comparison of our data to the current build 
3.0 of the bovine genome indicates that linkage-mapping methods are needed to 
better align genes and linkage maps correctly.  Within the PRKG2 gene alone, there 
were 50 SNP mutations detected by sequence comparisons across a three breed 
panel of cattle.   The subset of these mutations used for linkage-mapping showed an 
amazing range of variation in haplotype phase across SNPs. This could be caused 
by an inter-genic recombination hotspot in PRKG2.  Alternatively, this maybe an 
area that is simply prone to mutation, based on the number of SNPs detected by 
limited sequencing of the PRKG2 gene. If this were the case, selection for other 
favorable genomic regions in this portion of the genome may result in unexpected 
haplotype combinations due to the advent of recent mutations.  Since chromosome 
6 in cattle harbors the greatest number of QTL for production traits in cattle, areas of 
increased mutation rate would have great impact on what markers may be useful for 
selection in current breeding schemes. Understanding the genomic variability within 
such small regions of the genome will require more research in the area of genome 
assembly to assist researchers conducing both linkage-mapping and genome 
assembly research. 
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 The mutation for dwarfism in Angus is located on chromosome 6, along with 
numerous QTL for production traits.  Of particular interest are QTL for growth rate, 
milk yield, and milk fat and protein that would be selected upon for optimal calf 
growth and maternal ability (see http://bovineqtl.tamu.edu/ [24], 
http://www.vetsci.usyd.edu.au/reprogen/QTL_Map/ [25], 
http://www.animalgenome.org/QTLdb/cattle.html [26].)  It is possible that selection 
for improvement in these traits inadvertently led to the increased appearance of 
dwarfism.  Additionally, the Angus breed went through a transition period where 
animals were selected to be short and stocky.  It is possible that the occurrence of 
the mutation is a hold over from earlier years when smaller frame size was desired.   
The function of PRKG2 remains widely unknown, but it is clearly an important 
signal transduction pathway.  PRKG2 has been documented to have important roles 
in numerous tissues (e.g. brain, growth plate cartilage, jejunum, kidney, lung, and 
pancreas.)  Its potential roles are diverse, ranging from kidney disease, and cancer 
to chondrodysplasia [27, 28].  Several important roles in biology have been 
discovered.  First, the knockout of PRKG2 shows no symptoms of infection when 
treated with STa toxin of E.Coli [23].  The role of PRKG2 in transport of Na+, H+, 
HCO3-, Cl-, and water have been well documented in the small intestine [23, 29,30].  
Additionally, PRKG2 has been shown to be highly expressed in the brain with a 
largely unknown function (http://www.brain-map.org/welcome.do; jsessionid= 
9E20382C06C915BADE5541E1AD79D9CA) [31].  Intriguingly, study of PRKG2 
knockouts indicate that PRKG2 may regulate the circadian clock, behavior, and 
alcoholism [32-35].     
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 The use of PRKG2 as a therapeutic treatment in medicine has considerable 
potential.  It was previously suggested by Pfeifer et al. [10] that PRKG2 could be 
used to enhance the process of bone healing.   More recently, it has been suggested 
that the protein kinase G pathway may be important in developing treatments for 
diabetes [36].  The role of PRKG2 to regulate the CFTR is particularly interesting.  
Analysis of the PRKG2 pathway along with cAMP pathways may yield valuable 
information needed to create new treatments for cystic fibrosis patients.  
Understanding regulation both upstream and downstream of PRKG2 will be critical 
in such developments.  With so many roles, PRKG2 is a gene that will require many 
additional studies.  As unlikely as it may seem, the Angus dwarf may be a useful 
model to study the role of PRKG2 on physiology. 
 We present a strong argument that a nonsense mutation at R678Z of PRKG2 
causes dwarfism in Angus cattle. First, the mutation is 100% concordant with the 
pedigree including both dwarves and dwarf carriers.  Second, all known carriers 
have one copy of the mutation.  Third, the mutation causes a premature stop codon 
in a kinase domain.  Structural analysis suggests the protein structure is greatly 
altered due to this mutation.  Fourth, and most importantly, knockout mouse and 
naturally occurring rat mutation in PRKG2 cause dwarfism with growth plate 
phenotypes similar to cattle.  In addition, a breeding experiment verified that the 
R678Z PRKG2 marker could predict dwarfism status.  Last, transfection 
experiments, and expression analysis from dwarf and normal cattle demonstrate that 
this mutation alters COL2 and COL10 expression levels.  Since COL2 and COL10 
levels are critical to proper growth plate development, it is likely that such a 
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functional change will alter growth plate development, preventing proper 
endochondral ossification.   
CONCLUSIONS 
 The evidence presented demonstrates that the R678Z is most likely a 
causative mutation for dwarfism in American Angus cattle. Time will reveal whether it 
is the only mutation or one of several in the breed.  The immediate impact of this 
research is a genetic test for use by Angus producers to remove dwarfism.  
Ironically, a trait that greatly frustrated Angus cattle breeders for decades may now 
provides clues about the function of PRKG2, which has implications for human 
health.  Continued research on knockouts and naturally occurring PRKG2 mutants 
may unlock the doors to medical treatments for many debilitating genetic diseases.  
Additional functional analysis is underway to characterize the impact of the R678Z 
PRKG2 mutation on bovine physiology.   
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FIGURE AND TABLE LEGENDS 
 
Figure 1.  A four-generation pedigree consisting of 26 individuals was used for 
linkage-mapping.  These 26 individuals included 8 males (sires), 10 females (dams), 
and 8 calves (dwarf and normal phenotypes). 
Figure 2.  Linkage analysis of Bos taurus autosome 6 microsatellite marker pairs 
with Angus dwarfism.  The disease allele was fitted at the center of the two marker 
haplotype.  The Logarithm of odds (LOD) score is maximized at 7.34 between 
markers AFR227 and BM4311.  The dashed line indicates the significance 
threshold, LOD=3.  Arrows represent the position of microsatellite markers. 
Figure 3.  Fine-mapping of the critical region associated with bovine dwarfism on 
BTA6.  The LOD score was maximized at 7.89 between markers AFR227 and 
BMS511.  The dashed line represents modeling of the disease with a higher disease 
allele frequency (0.0001), while the solid line represents modeling of the disease 
allele with a low frequency (0.00001).  The dashed line indicates the significance 
threshold, LOD=3.  Arrows represent the position of microsatellite markers. 
 90
Figure 4.  A C/T nonsense mutation in exon 15, R678Z marker, of PRKG2 follows 
segregation from carrier to dwarf and is not present in unaffected Angus, Hereford or 
Brahman cattle. 
Figure 5.  The maximum LOD score for Angus dwarfism on BTA6 occurs at the 
C/T nonsense mutation in exon 15, R678Z marker,  of PRKG2.  The dashed line 
indicates the significance threshold, LOD=3.  Arrows represent the position of single 
nucleotide polymorphism and microsatellite markers. 
Figure 6.  Comparison between normal and dwarf cattle PRKG2 proteins. 
Figure 7.  Comparison of the primary amino acid sequence across 7 species at the 
exon 15 PRKG2 mutation . 
Figure 8.  Collagen (COL) 2 and 10 mRNA expression levels in Angus dwarf 
versus normal cattle.  A) Comparison of COL2 mRNA expression levels between 
wildtype btPRKG2 and R678Z  btPRKG2 transfected HUH-7 cells.  B) Difference in 
COL2 expression in R678Z PRKG2 homozygous genotypes versus unaffected 
R678Z PRKG2/ +  cattle growth plate.  C)  Difference in COL10 expression in R678Z 
PRKG2 mutants versus versus unaffected R678Z PRKG2/ + cattle growth plate.   
Table 1.  Primer Sequences and PCR conditions.  1PCR reaction conditions were 
as described by manufacturer (Promega; Madison, WI) 
Table 2.  SNaPshot primers used to genotype markers flanking the R678Z 
mutation.  1All primers are given in 5 to 3 orientation.  Conditions of all single base 
extension was the same: 1) 96ºC for 10 seconds, 2) 50ºC for 5 seconds, 3)  60ºC for 
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30 seconds, 4) Repeat steps 1 through 3 for 24 more cycles, 5) Store product at  
4ºC 
Table 3.  Enzymes used for RFLP tests in markers flanking the R678Z mutation.  
 1 Digest conditions were as described at:  
http://www.neb.com/nebecomm/products/category1.asp?#2 [36] 
 All digests were done overnight. 
Table 4.  Single nucleotide polymorphism frequency and informativeness in 10 
SNPs in positional candidates BMP2K, and PRKG2 used for fine mapping of an 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
     













































































































































































































































































































































































































































Gene Position SNP Enzyme1 
PRKG2 Intron 1 A/G Mse I 
 Intron 2 C/T BstZ17 I 
 Intron 3 A/G Bsr I 




Gene Position Alleles Frequency 
BMP2K 5 UTR A/G A=82% 
G=18% 
  Intron 10 C/T C=44% 
T=56% 
  3 UTR C/T C=62% 
T=38% 
PRKG2 Intron 1 A/G A=40% 
G=60% 
  Intron 2 C/T C=14% 
T=86% 
 Intron 3 A/G A=22% 
G=78% 
  Intron 6 A/C A=38% 
C=62% 
  Exon 15 C/T C=46% 
T=54% 
  Intron 16 C/G C=42% 
G=58% 
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ABSTRACT 
 Fine-mapping projects require a high density of SNP markers as well as 
positional candidate gene sequences.  In species with incomplete genomic 
sequence (e.g. cattle prior to 2006), the DNA sequence within a linkage analysis 
confidence interval may or may not be known.  Annotation and assembly of short, 
incomplete DNA sequences is time consuming and not always straightforward. We 
have created a tool called BEAP that combines BLAST and CAP3 to retrieve and 
construct contigs for localized genomic regions in species with unfinished sequence 
drafts.  The rational is that a template genome, such as human genomic sequence, 
can be used to query genomic sequence from a species of interest (e.g. cattle, pig, 
sheep).  The user must define what template sequence is appropriate based on 
radiation hybrid (RH) map data or other evidence linking the gene sequence of the 
template species to the target species.  We provide a summary of test results using 
BEAP to determine how different options and genomic structure affects contig 
construction.  BEAP is a tool that could expedite the process of positional cloning of 
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genes responsible for quantitative trait locus (QTL) variation in species without a 
completely sequenced genome.  We demonstrate how BEAP was used to generate 
genomic template sequence used to positionally clone the mutation responsible for 
Angus dwarfism.   
INTRODUCTION 
Angus dwarfism has been a source of economic loss to Angus cattle breeders 
for over 60 years.  Linkage-mapping suggested that the Angus dwarfism locus was 
located on Bos taurus autosome 6 (BTA6). Ideally, an accurate genetic marker for 
Angus dwarfism was needed to give producers a tool to eliminate dwarfism from the 
Angus breed.  The most accurate genetic marker would be the causative mutation. 
Accordingly, the process of fine-mapping the mutation responsible for Angus 
dwarfism began before the completion of the bovine whole-genome sequencing 
project.  Without whole-genome sequence, it was difficult to define what genes and 
existing genetic variation was present in the bovine dwarfism locus on BTA6.  
Additional DNA sequence was required within the dwarfism locus to generate new 
SNP markers for fine-mapping and assessment of positional candidate genes.   
Fine-mapping causative mutations at the DNA level without whole-genome 
sequences is a time consuming process that requires localized genomic sequencing, 
assembly and annotation.  The recent completion of many whole-genome 
sequencing projects is an invaluable resource that will greatly expedite the fine-
mapping process.  Genome assemblies provide a majority of gene sequences.  
Assemblies also allow anchoring of genetic maps to physical maps, a vital 
component in identifying the gene content underlying QTL and disease loci in the 
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genome.   The human genome is often used as a template to find DNA sequences 
and syntenic chromosomal blocks of genes between species.  Such comparisons 
are useful in initial sequencing projects.  Many genomes are now sequenced, but the 
process will continue for many years to come, because of the power of comparative 
genomics to help define gene function.  In the interim, draft sequences are available 
for many species.  
 A variety of computational methods have been developed to analyze and 
assemble sequences.  Perhaps the most commonly used method for sequence 
comparison is the basic local alignment and search tool (BLAST) [1, 2].   Other tools 
such as VISTA [3], and CLUSTALW [4] are also available, but each was originally 
designed to serve slightly different tasks.  Neither of these methods have as many 
options for adjustment of sequence retrieval or assembly analysis as BLAST.  
Template genomes are often used to retrieve orthologous genetic sequence for 
annotation and wet lab gene characterization experiments.  However, these gene 
sequences are often in short, shotgun sequence sizes or small contigs at best.  
Sequence assembly programs, such as CAP3, have been widely used to assemble 
genomes into contig scaffolds[5].  More recently, new programs such as PCAP, 
Arachne, and MAGI have been used to assemble genomes with more flexibility [6-8]. 
[J34] 
Unfortunately, these programs require more computing power and are difficult to 
implement compared to CAP3.  
 We introduce BEAP, the BLAST Extension & Alignment Program as a tool to 
assemble localized genomic regions.  The objective of the BEAP program is to 
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assemble DNA sequences into contigs based on a reference genome.  The goals of 
BEAP are to: 1) create contigs within a genomic area of interest (i.e. QTL confidence 
interval); 2) annotate sequence based on comparison to a reference genome; and 3) 
allow comparison of genomes at the gene level for small chromosome blocks.  
Optimally, BEAP would assemble 1-5Mb genomic regions into contigs when a 
complete sequence draft is not available.  The assembled contigs could then be 
used by geneticists as template sequence for primer design in the process of fine-
mapping and positional cloning of QTL or single gene mutations. [J35]  Herein, we 
describe the performance of BEAP as well as an example of how BEAP was used to 
create contigs used as template to positionally clone the mutation responsible for 
Angus dwarfism. 
MATERIALS AND METHODS 
Selection of template sequence   
The appropriate template sequence must be defined by the user. The 
template sequence is used much like a primer for BLAST to query the species of 
interest.  Most often, cross-species comparative maps can be used to identify 
syntenic sequence blocks between species to find a suitable template sequence. 
Upon retrieval of all sequences, CAP3 was used to build contigs.  The end result is 
sequences that can be used for positional cloning of candidate genomic regions that 
contain a QTL or disease gene.   
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Bundling of computation tools and processes to achieve the BEAP method 
Expediting a localized genomic assembly requires efficient combination of 
computational tools[J36].  BLAST and CAP3 processes were linked via perl scripts to 
create a pipe-line for sequence assembly (Figure 1).  BLAST was looped in an 
iterative process such that after all queries, each unique sequence was used as 
template sequence of the next round of BLAST analysis against the initial 
databases.  A filter was created to remove repeated sequences that were retrieved 
multiple times with different templates.  This limits the number of frivolously repeated 
processes.  The number of BLAST rounds was also monitored such that only the 
required number of BEAP rounds were performed, up to a maximum number defined 
by the user.  This method allowed BEAP to stop the re-iterative BLAST process 
early if no new sequences were retrieved.  This monitoring software reduced the 
amount of time needed to complete a BEAP assembly.  A summary was also kept 
throughout the process to keep track of sequences retrieved and the corresponding 
statistics.  After all sequences were retrieved, they were sent to CAP3 for assembly 
using the default settings and available sequence quality files from NCBI.  The 
BEAP program was developed and tested on a 533 MHz dual processor linux 
computer with 8 GB RAM[jk37].   
BEAP program options 
 Genome assembly is in some ways more of an art than scientific process.  
Researchers need to have some flexibility to adapt to each new genome depending 
on genomic complexity and gene content.  A variety of options in the BEAP process 
were designed to help researchers tackle these challenges.  BEAP is not limited to 
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bovine sequence.  Any sequence database could be searched.  The user can 
specify local (megaBLAST) or remote database (BLASTn) querying, stringency of 
BLAST hits (e-value), and word size within the megaBLAST option.  Once template 
sequence was[J38] retrieved, it is[J39] used in a repetitive BLAST process to perform 
in silico chromosome walking by sequence similarity search, match and extension.  
This repetitive BLAST process was repeated within all databases until no new 
sequences were retrieved.  The number of BLAST rounds performed can be varied 
based on need.  Any DNA sequence that was retrieved multiple times was removed.  
Sequences were then assembled into contigs by CAP3.  A configuration file was 
used to define query databases, blast methods, stringency filters (e-value, 
wordsize), [J40]input and output files for BEAP.   
Retrieval of template sequence 
 In our test case, we defined the best template sequence to be used as that 
resulting from RH map data.  Bovine genetic markers were used to find the human 
syntenic gene block that corresponded to the bovine chromosomal block of interest.    
Genes and pseudo genes were deemed template sequence as the conservation 
between species is greatest in genic regions.  Gene sequences were used from a 
species with a fully sequenced genome, the template sequence (i.e. human), to 
identify the orthologous genes within a species of interest (i.e. cattle).  The feasibility 
of BEAP to construct contigs using intronic sequence as template was tested. All 
template sequences were retrieved from UCSC golden path genome browser at 
http://genome.ucsc.edu/ [9] and the ENSEMBL database at 
http://www.ensembl.org/index.html [10].  Repetitive sequence is often a hindrance to 
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genomic assembly programs because they occur in multiple sites across the 
genome with wide variation in flanking genomic sequence.  Repetitive sequences 
were masked using RepeatMasker software [11].  Cattle (Bos taurus) sequence was 
used in all tests of BEAP performance.  The new trials with BEAP used the full 
genome sequence, version 3.0.   
Default settings used to assess BEAP performance 
 All trial runs of BEAP used the same settings, with the exception of the factor 
tested.  A summary of the test performed is provided in Table 1.  Default test 
settings used network BLAST to query six databases at NCBI, include: Bac end 
sequence, trace expressed sequence tagged sites (EST), trace other sequence, 
trace whole genome sequence (WGS), high throughput genome sequence (HTGS), 
and EST databases. The e-Value was set to e-30 and no additional adjustments 
were made.  The databases queries using megaBLAST were always the same, and 
included the Bos taurus unique sequence and Bos taurus tiger gene databases.  
The e-Value was adjusted as needed to attempt to force BEAP to run when no result 
could be obtained.  Additionally, megaBLAST and network BLAST options were 
compared when possible to find solutions to allow for retrieval of query sequence.  
Changes in e-Value and BLAST type are reported only when one method was 
successful and the other method was not successful in creating contigs.   
Application: The use of BEAP to construct contigs within the Angus dwarfism 
locus 
 Fine-mapping of the Angus dwarfism locus resulted in a critical region of 
roughly 1Mb on BTA6.  Since the bovine genome was not fully sequenced, many of 
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the candidate genes in this genomic region were unknown and unannotated. The 
initial assembly of the Angus dwarfism locus was performed using this early 2005 
sequence draft.    The Human-Bovine RH map was used to define the template 
sequence, Homo sapien autosome (HSA) 4 from :78,000,000 to 83,000,000 
megabases (Mbps).  This genomic block contained 20 genes and pseudo-genes 
[12].  The template sequence included both exonic and Untranslated Region (UTR) 
sequences.  We used RH markers within genes in both genome builds to anchor 
one map to the other. The same e-value, e-30, was used for all tests.  Databases 
tested were the same six listed above as default for the network BLAST tests.  
RESULTS 
Influence of repetitive sequence 
 To determine the effect of repetitive sequence elements on BEAPs contig 
number and size output, we tested how BEAP would handle sequence with and 
without repeat masking.  Each BEAP test was performed with or without repetitive 
sequence using a 200 kilobases (kbs) region of HSA4 from 13-13.2 Mbs as the 
template.  Using Repeat masker, 14 contigs were constructed ranging in sizes from 
493 base pairs (bps) to 2,147 bps with an average size of 1,330 bps.  All contigs 
totaled 18,612 bps.  The same analysis without repeat masker constructed 15 
contigs with nearly identical contig sizes.  The total number of bases constructed into 
contigs was 20,021 bps.   
 The level of repetitive sequence was tested to determine BEAPs tolerance 
level and performance with varying levels of repetitive sequence elements.  
Repetitive sequence elements were evaluated with RepeatMasker and unmasked 
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sequences with total repetitive sequence ranging from 0% to 50% were used as 
template for BEAP.  All sequences analyzed with BEAP were approximately 20 kbs 
in size.  Template sequence with 0% repetitive sequence resulted in 24 contigs with 
an average size of 1,825 bps ranging in size from 254 bps to 6,117 bps.  The total 
number of bases constructed into contigs was 43,803  bps.  With 10% repetitive 
template sequence, seven contigs were constructed with an average size of 1,152 
bps spanning a range of 493 bps to 1,561 bps.  The total number of bases 
constructed into contigs was 8,062 bps.  With 50% repetitive template sequence, 
five contigs were constructed with an average size of 4,246 bps, with contigs ranging 
in size from 393 bps to 19,001 bps.  A total of 21,228 bases were queried and 
constructed.  Results are summarized in Figure 2.   
Capacity to handle total template sequence size 
To determine if BEAP could handle blocks of sequence comparable to the 
size of a QTL confidence interval, total template input size was tested.  Human 
genomic sequence blocks of 50 kbs, 1 Mbs and 5 Mbs were used as BEAP template 
sequence.  Each sequentially larger genomic segment contained the same 
sequence as found in the smaller template file, plus additional sequences to make 
the larger template size.  The 50 kbs template sequence was processed resulting in 
three contigs with an average size of 5,198 bps and a range of 4,117 bps to 7,342 
bps.  A total of 15,594 bps were queried and constructed.  The 1 Mbs template size 
resulted in 31 contigs with an average size of 1,750 bps ranging in size from 740 bps 
to 7,301 bps.  A total of 54,338 bps were queried and constructed into contigs.  Last, 
a 5 Mbs segment of template sequence was placed into the BEAP program.  Initially, 
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the computer used the maximum amount of memory and was unable to process the 
data.  Additional trials were performed with two different segments of the genome.  
The amount of unmasked sequence varied greatly; however, BEAP was unable to 
process the data without exhausting the available memory.  In order to construct 
contigs, the e-value had to be increased and fewer databases (2) were queried 
using the megaBLAST option instead of network BLAST.  Raising the e-Value to e-
120 and using megaBLAST finally resulted in constructed contigs.  There were 18 
contigs constructed at an average of 208 bps per contig.  A total of 3,747 bps were 
constructed with minimum size of 80 bps and maximum size of 1,000 bps.  
Influence of querying BLAST databases on a local server vs. the web 
Computation time is an important factor in the assembly process.  To 
compare contig size and number, megaBLAST and network BLAST options were 
tested to assess the feasibility of using local vs. web based sequence database 
querying.  Both methods used an e-Value of 1e-30.  The megaBLAST option was 
set to a wordsize of 20.  The local BLAST queried two databases, where as the 
network BLAST queried 6 databases.  A total of 22 contigs were constructed using 
the network BLAST method with an average size of 2,815 bps and a total of 59,117 
bps constructed.  The maximum contig size was 9,981 bps and the minimum was 
493 bps.  The local BLAST method resulted in 14 contigs constructed with a total of 
42,779 bps.  The average contig size was 3,056 bps with a maximum size of 10,325 
bps and minimum size of 383 bps. 
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The influence of adjusting network BLAST settings on BEAP contig number 
and size 
The optimal e-Value was tested using e-Values ranging from e-30, e-60 to e-
120.  The same template sequence was used for all tests.  The results from e-30 
were 33 contigs consisting of a total of 87,453 bps for all contigs.  The maximum 
contig size was 11,225 bps and the minimum was 430 bps.  Using e-60 as the 
threshold resulted in 25 contigs with an average size of 3130 bps and a total size of 
78,259 bps summed across all contigs.  The maximum contig size was 11,225 bps 
and the minimum was 753 bps.  When the e-Value threshold was raised to e-120, 17 
contigs were constructed with an average size of 3,979 bps and a total of 67,644 
bps for all contigs was constructed.  The maximum contig size was 11,225 bps and 
the minimum was 1,239 bps.  A summary of results are provided in Figure 3.   
Impact of adjusting the word size of megaBLAST on contig number and size  
 In the megaBLAST option, three different word sizes were tested, 10, 30, and 
60.  The test using 10 as the word size resulted in 14 contigs with an average size of 
3,056 bps and a total size of 42,779 bps constructed for all contigs.  The maximum 
contig size was 10,325 bps and the minimum size was 383 bps.  Adjusting the word 
size to 30 resulted in nearly the same results, with only negligible changes in the 
size of one contig.  Changing the word size to 60 resulted in 9 contigs with an 
average size of 4,243  bps and a total of 38,189 bps across all contigs.  The 
maximum contig size was 10,320  bps and the minimum was 2,089 bps.  A summary 
of results are provided in Figure 4.   
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Application: An analysis of the Angus cattle dwarfism locus 
 Table 2 presents a summary of the genes retrieved and a sequence similarity 
comparison to human.  The sequence similarity between human and cattle ranged 
from 85.3% to 95.1%.  An example of assembled sequence is presented in Figure 5 
along with an alignment of an individual sequence member to a constructed contig 
using NCBIs BLAST 2 sequences tool [13] to demonstrate how BEAP extended 
template sequences. 
DISCUSSION 
Concerns and limitations- considerations when using BEAP 
 As with any method, BEAP has limitations that need to be considered by the 
user to gain the most benefit from the program.  Contigs created in the Angus 
dwarfism locus demonstrate its utility.  The tests conducted to assess BEAPs ability 
to handle various sequence conditions revealed several concerns.  First, BEAP is 
not designed to handle repetitive sequence. Therefore, it is necessary to use 
RepeatMasker prior to entering template sequence into BEAP.  Creating a sequence 
preparation step using RepeatMasker prior to the BEAP process may be an option 
for future improvement of the tool. The danger of increasing the amount of repetitive 
sequence is that fewer contigs appear to be constructed with increasing repetitive 
sequence content in the BEAP template sequence.  Also, there is greater risk of 
constructing a contig incorrectly with increased repetitive sequence, because 
repetitive sequences occur multiple times across the genome making it possible to 
BLAST retrieve the same repetitive sequence from a different chromosome or 
linkage group.  Initially, we tried to allow BLAST to retrieve sequences with repetitive 
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elements in hopes that contigs constructed by CAP3 would remove repetitive 
sequence as singlets.  This was not feasible as we found nearly 40% repetitive 
sequence in contigs created by CAP3.  These SINEs, LINES, LTRs, and other DNA 
repetitive elements were detected using Repeat masker (data not shown).  The 
trend in contig size observed with increased percentage of repetitive sequence 
elements requires some explanation.  At low levels of repetitive sequence, fewer 
contigs were created with shorter average contig size, suggesting that BEAP may be 
filtering out repetitive sequences as singlets in the CAP3 process.  A post assembly 
analysis with RepeatMasker shows that the contigs constructed using template 
sequence with 10% repetitive sequence elements contained only 7% repetitive 
sequence.  In comparison, the template sequence containing 50% repetitive 
sequences produced larger contigs, but these contigs were composed of 56% 
repetitive sequence elements.  Assembly with a considerable amount of repetitive 
sequence queries more repetitive sequence.  Due to the risk of querying genomic 
sequence from a different genomic region, repetitive sequence should be minimized 
in BEAP.  These initial results stimulated our tests to determine the influence of 
repeat sequence on BEAP contig construction.  CAP3 was selected as a means to 
construct sequences in contigs, because it is widely used by biologists and well 
tested with real data. Repetitive sequence elements, gene deserts, centromeric 
regions and other low complexity DNA elements inhibit sequence assemblers ability 
to create contigs that span large distances. In the future, other sequence 
assemblers, like PCAP or the MAGI scheme used by the maize genome may be 
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more effective at piecing together large or repetitive sequence elements of the 
genome.   
The capacity of BEAP to handle large datasets was also a concern.  Datasets 
containing template sequence up to 1Mbs in size appear to be manageable for 
BEAP.  However, larger datasets up to 5Mbs appear to be difficult for BEAP to 
construct.  It should be realized that any increase of the input sequence size will 
exponentially increase the returned matching sequences. The ability to construct a 
genomic region is highly dependant on the number of genes and coding regions in a 
given genomic space.  Computational power also alters how many contigs can be 
constructed.  With more powerful computers, more contigs could be created.  The 
ability to increase the e-Value stringency is helpful, however, researchers may 
discard good sequence members for a contig by making thresholds for a sequence 
match in BLAST too stringent.  Using local databases is one good alternative 
strategy.  MegaBLAST could build a 5Mbs region with a threshold of e-120 in our 
test.  There is also some concern that BEAP is losing some sequence as singlets 
that are good matches to desired genomic sequences.  These sequences need to 
be saved separately for use as primer templates and annotation purposes.  
Analysis of BEAP settings on contig size results- recommendations for BEAP 
use. 
 Comparing various features for BEAP revealed several characteristics about 
BEAPs running capacity.  Using network BLAST resulted in the most sequence 
queried and contigs built.  However, sometimes computational time for network 
BLAST required hours compared to minutes for local BLAST.  In addition, contig 
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sizes were generally the same for network versus megaBLAST.  It was difficult to 
assess the difference in efficiency and productivity of megaBLAST vs. network 
BLAST, because the same databases could not be tested.  The change in contig 
size created and total sequence queried was very similar between the two methods.  
Yet large differences were observed in computation time, hours for network BLAST 
compared to minutes for megaBLAST.  This would suggest that megaBLAST on a 
local database is considerably faster for creating contigs with BEAP.  As expected, 
reducing the e-Value to e-30 compared to e-60 or e-120 resulted in the most 
sequence queried and contigs created.  Changing the word size in megaBLAST 
likewise resulted in the most contigs when the word size was smallest, 10, versus 
settings of 30 or 60.  The idea of changing word size is to require a larger string of 
nucleotide matches for BLAST to classify a sequence as a good match to the 
template.  However, there was very little difference in the number or size of contigs 
created using a word size ranging from10  30.   
Based on these results, the user would optimally download as many 
databases as possible onto a local server with considerable computational power, 
(8Gb RAM).  Template sequence would be available by comparing the species to a 
fully sequenced template genome using a RH map. The template sequence 
would be composed of 1-5 Mbs of sequence processed for repetitive sequence with 
a program like RepeatMasker.  Then, the MegaBLAST option could be used to 
query the desired local databases with an e-Value of e-30 and a word size of 10 or 
smaller.  Higher e-Values or smaller chunks of template sequence could be used to 
compensate for large template input sequence sizes.   
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Assessment of bovine dwarfism locus assembly 
 Analysis of the Angus cattle dwarfism locus demonstrates the potential 
application of BEAP in a low draft sequence.  Our initial test using pre-genome 
assembly sequence from cattle created a large number of contigs, encompassing 
the vast majority of genic regions and flanking intronic sequence for the dwarfism 
locus.  Nineteen genes were identified in cattle based on BLAST results.  Use of 
current sequence draft data for the cow also created a wealth of sequence data for 
positional cloning of the locus.  The ability to use local and network databases 
shows the flexibility of BEAP for different researchers needs.  The sequence data 
created was used to design primers for positional candidate gene analysis and 
eventually for the discovery of the causative mutation for Angus dwarfism.   
Additional areas for future refinement of BEAP 
 Future plans for BEAP are to create a web based interface to allow public 
access.  A visualization tool is also being constructed to view contigs and contig 
members.  Part of this process will be to evaluate the possible mistakes in contig 
construction for sequences that do not overlap well with other sequence in the 
contig.  In addition, we are exploring methods to include whole BAC sequence to fill 
in gaps between contigs.  We will create a comparative viewer to assess how well 
BEAP is constructing contigs.  A variety of additional features are in the pipeline for 
potential application.  It is important to allow many options for the user to access the 
most appropriate template sequence for their analysis.  Therefore, we will provide 
links to major sequence databases like ENSEMBLE, TIGR, NCBI and UCSC, as well 
as RH maps comparing livestock species to human.  Currently, we have chicken, 
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pig, cattle, non-redundant (nr), mouse, and several human databases locally 
available with BEAP.  In the future, we would like to investigate the use of txBLAST 
(protein homology) to help query difficult sequences.  Additionally, we would like to 
add a front end template sequence processing component to screen template 
sequence for repetitive sequence elements.   
CONCLUSIONS 
 The BEAP tool is one method for querying and extending existing genomic 
sequence in a genome that is not fully sequenced.  BEAP can help researchers find 
template sequence for positional cloning and discovering of SNP markers.  
Limitations for BEAP may not allow all users to assemble contigs within their 
genomic area of interest.  It is vital that good template sequence be defined for the 
BEAP process and that repetitive sequences are minimized prior to using BEAP.  
The results presented describe how BEAP can be used to create contig sequences 
in cattle prior to the completion of sequencing.  The results demonstrate that BEAP 
was capable of producing contigs useful for fine-mapping and candidate gene 
analysis that lead to the discovery of the Angus dwarfism mutation. Updates to the 
program will make it more widely accessible and improve BEAPs ability to construct 
contigs.  The use of BLAST comparisons to other annotated species will allow a new 
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FIGURE AND TABLE LEGEND 
 
Figure 1.  Schematic of the BLAST Extension and Alignment Program (BEAP).  
The idea is to take a template sequence and BLAST it against a species of interest 
for a localized chromosomal block ≤ 5 Mbs to do in silico positional cloning.  The 
process is used repetitive BLASTs to take retrieved sequence for use as template in 
2nd, 3rd, etc. BLAST rounds until very little new sequence is retrieved based on a 
threshold.  Once BLAST is completed, CAP3 assembles the sequence to create 
contigs for downstream analysis. 
Figure 2.  The relationship between percentage of repetitive sequence elements in 
BEAP template and size and number of contigs assembled.  A) A non-linear trend in 
average contig size with increased input of repetitive sequence as template 
sequence for BEAP.  B) Decreased number of contigs produced by BEAP when the 
percentage of repetitive sequence elements in the template sequence is increased.   
Figure 3.  The impact of increased e-Value stringency on A) average contig size, 
and B) number of contigs constructed. 
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Figure 4.  The effect of increased word size on A) average contig size, and B) 
number of contigs constructed. 
Figure 5.  Contigs created in the Angus cattle dwarfism locus by BEAP, aligned to 
a sequence retrieved from NCBI using the align two sequences tool at NCBI.  
Previous to the creation of these contigs, no sequence data was available for the 
PRKG2 gene.  The alignment shows both successful retrieval of target sequence in 
cattle and nearly tripling in the size of the template for primer design and lab analysis 
(883 bps for individual sequence vs. 2237 bps for constructed contig).  The score, 
expect, identity and gap statistics show the contig was used in its entirety, with no 
gaps and 100% sequence match. The queried sequence was used for primer design 
used to fine-map the causative mutation for dwarfism in Angus cattle. 
Table 1.  Tests performed with BEAP under various conditions.  Without 
RepeatMasker was a test of the same sequence with and without repeat masking.  
The sequence source trial was performed with sequence from UCSC and 
ENSEMBL.  Comparisons of megaBLAST vs. netBLAST were also performed with 
the same sequence, but different databases.  Default settings for testing were 
netBLAST using six databases, including: Bac end sequence, expressed sequence 
tagged site (EST), EST trace, other trace sequence whole genome shotgun 
sequence trace, and high throughput genome sequence databases and an e-value 
of 1e-30.  Tests performed on BEAP under simple, intermediate and complex 
scenarios.   
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Table 2.  Summary of gene sequences retrieved from the 2005 bovine sequence 
draft by the original version of BEAP using exonic and UTR sequence for the genes 














































































































































































































Test Simple  Intermediate Complex 
Genomic content Exon only Exon + UTRs All Exon & Intron 
sequence 
Input seq. size <1000 bps 1000-5000 
bps 
>5000 bps 




1000 input seq. 
Optimal e-Value e-30 e-60 e-120 
Word size 10 30 60 
# databases 1 6 12 
# BEAP rounds 10 30 60 
Amount repetitive 
seq 
0% 10% 50% 
Total template 
input 
50 kbs 1 Mbs 5 Mbs 
Without repeat 
masker 
   
Sequence source    
Local 
(megaBLAST) vs. 
remote (netBLAST)  
database 
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ABSTRACT 
 The PRKG2 gene is important to growth plate development, because it is 
required for proper endochondral ossification. Regulation of SOX9 by PRKG2 
determines when a switch from proliferative to hypertrophic growth occurs in growth 
plate chondrocytes.  Loss of PRKG2 function in rodent models results in dwarfism.  
Angus dwarfism is caused by a non-synonymous R678Z mutation in cGMP-
dependant, type II, protein kinase (PRKG2).  Gene expression experiments indicate 
that Angus dwarves are likely null PRKG2 mutants.  To better understand the 
molecular pathogenesis and signaling pathways under the influence of PRKG2, we 
used microarray technology to evaluate gene expression profiles in the growth plate 
of PRKG2R678Z/R678Z, dwarf, and PRKG2R678Z/+, normal, cattle.  Differentially 
expressed genes were declared significant using a nominal p<0.05 at three different 
photomechanical transfer unit (PMT) scanning levels, resulting in 1541 genes 
differentially expressed at PMT 70, 1064 genes at PMT 80, and 788 genes at PMT 
90.  Changes in gene expression in collagen 2, 9, and 10 and WNT5a are consistent 
with increased expression of proliferative growth markers in PRKG2 null animals.  
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Differential expression of COL2, 9, and 10 was consistent with their promoter 
regulation by SOX9 binding elements. In PRKG2R678Z/R678Z cattle, these genes are 
up regulated. Expression of PRKG2 was reduced in PRKG2R678Z/R678Z cattle, 
consistent with nonsense-mediated decay in a truncated RNA message.  Expression 
differences were observed in multiple genes within large signaling networks, notably 
the MAPK and WNT5a pathways related to human achondroplasia and chondrocyte 
differentiation, respectively. Gene expression changes were also observed for 
biological processes of proliferation and calcium transport.  Two genes, COL2 and10 
were previous validated as differentially expressed by real-time PCR experiments.  
INTRODUCTION 
In 2002, a small surge in the number of dwarf calves born spurred Angus 
producers to call for new research into the cause of Angus dwarfism. Fine-mapping 
and functional analysis indicated that the R678Z mutation in the kinase domain of 
PRKG2 was a causative mutation for dwarfism in Angus.  Cell culture and in vivo 
expression of collagen 2 (COL2) mRNA indicates that the R678Z mutation has an 
expression phenotype comparable to null PRKG2 regulation of SOX9 [1]. These 
results closely mimic expression patterns in a naturally occurring PRKG2 mutant, the 
Kmi mini rat [2]. Therefore, it would seem plausible that the dwarf Angus is also a 
naturally occurring knockout of PRKG2.   
 The PRKG2 protein is a kinase with many diverse roles throughout the body.  
Knockouts of PRKG2 not only display dwarfism, they are also unaffected by E. coli 
infection as they do not recognize the STa enterotoxin [3].  This was the first hint that 
PRKG2 was a regulator of ion transport. PRKG2 is a critical regulator of the cystic 
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fibrosis transmembrane receptor (CFTR) in the intestines[4], lungs [5], kidney and 
pancreas [6, 7].  Other ion transporters regulated by PRKG2 include Na+/H+ 
antiporter 3 (NHE3) [8] and TRPV5/ECAC1 [9, 10].  In the kidney, PRKG2 functions 
as a key regulator of water transport [7].  Curiously, PRKG2 plays a role in multiple 
processes in the brain.  It acts as a regulator of the circadian clock, behavioral 
response, and alcohol tolerance [11, 12].  Little is known about the function of 
PRKG2 in the growth plate beyond regulation of SOX9 and its down stream 
effectors, COL2 and collagen 10 (COL10).   
 The majority of what is currently known about PRKG2 function in the growth 
plate comes from studies in the Kmi mini rat.  Chikuda et al. [2] elegantly show that 
PRKG2s kinase activity is required for nuclear translocation of SOX9 for adjustment 
of collagen expression from a proliferative (COL2) to a hypertrophic (COL10) state.  
The Kmi mini rat has a large deletion in PRKG2, rendering the protein non-function. 
More recent studies suggest that there may be an intermediate between PRKG2 and 
SOX9 signaling [13].  Crosses between PRKG2 and CNP knockout mice indicate 
that CNP is an upstream regulator of PRKG2 [14-16].  The CNP protein has been 
tied closely to both FGFR3 and MAPK signaling networks.  However, no direct 
studies have been performed to determine how FGFR3 and MAPK may interact with 
PRKG2.  The role of cGMP and NO, upstream triggers for PRKG2 signaling, have 
been tied to calcium signaling, apoptosis, and proliferation processes [17, 18]. 
Additionally, MAPK, NF-κB, PPAR-gamma, JNK, MMPs, VEGF, and CREB also are 
regulated by cGMP and NO [19].  Since cGMP and NO regulate PRKG2, PRKG2 
may also closely regulate cGMP and NO levels, fine-tuning growth plate 
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development.  No studies have dissected the role of PRKG2 regulation of global 
gene expression in the growth plate. The Angus dwarf provides a unique model to 
learn about the critical roles of PRKG2 in growth plate growth and development. 
 Cattle provide a good model to understand growth plate development. Bovine 
chondrocytes are used to understand cartilage growth and development [20, 21].  
The genomic complexity of cattle make them an appropriate genetic model for 
comparison to humans [22].  Transcriptional profiling of Angus PRKG2R678Z/R678Z 
(dwarf) versus PRKG2R678Z/R//+ (normal) cattle was used as a means to investigate 
the role of PRKG2 in the growth plate. Our objective is to understand the molecular 
pathogenesis of Angus dwarfism and potential PRKG2 pathway members. 
MATERIALS AND METHODS 
Biological samples 
 A breeding experiment was conducted to test concordance of the PRKG2R678Z 
mutation with the ability to predict dwarf phenotype. Calves were produced by 
standard embryo transfer methods.  More than half of the embryos failed to develop 
past day 60 post implantation.  Six calves, three from each mother were successful 
produced from segregate mothers in two calving groups.  These calving groups 
included animals born during the same week and were reared and euthanized 
together.  Expression and linkage mapping data [1] combined with previously 
developed rodent models [2,3] provided convincing evidence of the causality of the 
R678Z mutation in bovine dwarfism. 
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Tissue collection 
Calves were euthanized at approximately 210 days of age during a period of 
rapid long bone growth [23] .  Tissues were collected and preserved using RNA later 
(Ambion, Austin, TX).  Whole growth plate was collected from the tibia of all animals.  
Samples were archived at -80C until processed for RNA isolation. 
RNA isolation 
RNA was isolated from growth plate cartilage using a modified Trizol 
(Invitrogen, Carlsbad, CA) method.  A mass of 0.15 to 0.20 g of growth plate 
cartilage was placed into a sterile Petri dish.  One milliliter (mL) of Trizol was applied 
to each sample and samples were diced into a slurry of tissue using a sterile scalpel.  
Samples were then homogenized using a rotor star homogenizer at a total volume of 
6 mL Trizol.  Following the extraction protocol, sample yield was measured by 
spectrophotometer.  These yields were used to estimate how much purified RNA 
could be eluted from column purification (Qiagen, Valencia, CA).  RNA was stored at 
-80C until used for microarray analysis. 
Microarray analysis 
An Oligonucleotide 70 mer microarray created by the bovine microarray 
consortium was used to assay the expression of approximately 24,000 transcripts.  
Oligonucleotides were spotted in 48 sub-grids onto Corning GAPS II slides with 240-
µm spacing.  Slides were UV cross-linked prior to each hybridization.  Synthesis of 
cDNA was carried out using superscript II reverse transcriptase (Invitrogen, 
Carlsbad, CA) along with the Genesphere kit components.  Normal animals, 
PRKG2R678Z/+, were compared within calving group to each of the two dwarf, 
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PRKG2R678Z/R678Z, calves, resulting in two microarrays per calving group.  Cy 3 and 
Cy 5 dyes were used for differential display of cDNA binding between genotype 
treatments to the array.  Dye swapping was used for genotype comparisons to 
account for differential dye incorporation.  A total of four microarrays were hybridized 
to compare dwarf and normal animals using the Genisphere 3DNA 350HS 
hybridization kit (Genisphere, Hatfield, PA).  Microarrays were hybridized using GE 
Healthcare's Lucidea SlidePro hybridization oven (General Electric Healthcare, 
Piscataway, NJ) at the Iowa State University DNA facility according to manufacturers 
protocol.   
Scanning 
Hybridized slides were scanned for visualization of Cy3 and Cy5 signal using 
a Pro Scan Array HT scanner at microarray facility within the Iowa State University 
Plant Sciences Institute.  Slides were scanned at three different laser PMT 
intensities, 70, 80 and 90 PMT, to account for high and low expression levels of 
various transcripts.   Therefore, different genes will appear as expressed or not 
expressed at the different PMT levels.  Images were analyzed to obtain raw signal 
intensities and localized background signals with Imagene 5.1 software.   Text files 
were produced for each slide channel for statistical analysis.   
Statistical analyses 
Image files were normalized by channel to correct for background, differential 
dye incorporation using Lowess normalization [24], and heterogeneous variance by 
median centering using R scripts kindly provided by Dr. Dan Nettleton, Iowa State 
University.  Data was analyzed in a mixed model accounting for fixed effects of the 
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dye, genotype and calving group.  The slide was included as a random effect.  To 
account for random effects having an estimated variance of zero, we used the 
Kenworth-Rodgers correction.  Modeling and background correction was carried out 
as described [25].  Multiple testing analysis was performed by calculating q-values to 
determine false discovery rate (FDR) [26].  Also, a method developed by Mosig et al. 
[27] was used to estimate the number of potential differentially expressed genes.   
RESULTS 
Analysis of differentially expressed genes revealed that only a small portion of 
transcripts present on the microarray were expressed in growth plate cartilage.  An 
analysis using control Arabidopsis transcript probes, expected to be unexpressed, 
suggested no more than 4,500 of the 24,000 spots were truly expressed above 
background at PMT 70 (p<0.05).  This statistical test modeled the average of all 
Arabidopsis transcript expression versus each bovine spot within each grid of the 
microarray. Using a different approach [27] the number of true null tests was 
estimated.  This method estimated that up to 5,400 genes were potentially 
differentially expressed.  
The estimated number of genes differentially expressed at PMT 70, 80, and 
90 was determined using FDR.  The lowest FDR, corresponding to the lowest p-
value, for the three PMT levels was 0.54, indicating that 54% of all genes deemed 
significant were actually false positives at the lowest p-value.  A histogram of the 
respective p-values agreed with this result (Figure 1). Previous to this microarray 
experiment, two genes deemed differentially expressed by the microarray (p<0.05), 
COL10 and COL2, were declared differentially expressed by real-time PCR. Since 
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the statistical power to detect differences in gene expression was greatly reduced by 
embryo viability, and RNA quantity, biological function was used as a filter to select 
genes from the list of differentially expressed genes.  The rationale was that genes 
following an expression pattern as part of a signaling pathway or biological process 
were more likely to be truly differentially expressed. Therefore, a nominal p<0.05 
significance level was used for each PMT level to declare significance. 
A significance level of p<0.05 indicated 1541 genes differentially expressed at 
scanning PMT 70, 1064 genes at PMT 80, and 788 genes at PMT 90.  A summary 
of the number of differentially expressed genes for each PMT level is described in 
Figure 2.  In an effort to use biological evidence to overcome small sample size, 
pathways were analyzed to determine if genes were differentially expressed in 
logical patterns.  Pathways were constructed based on pathways constructed for 
public viewing at KEGG at http://www.genome.jp/kegg/pathway.html [28].  Genes 
were grouped by biological processes by assessment of gene function at the NCBI 
gene database at http://www.ncbi.nlm.nih.gov/sites/entrez [29].  Due to the lack of 
bovine gene annotation, pathways were queried manually and genes were placed 
into pathways based on database searches by hand.  Gene networks of interest with 
multiple genes differentially expressed include MAPK, and WNT signaling pathways.  
Gene network data is presented in Table 1.  In addition, several genes with SOX9 
promoter and enhancer elements were found to be differentially expressed (i.e. 
COL2, 9, 10).  Biological processes with multiple genes differentially expressed, 
included calcium transport/ regulation, proliferation, Golgi transport, cGMP regulated 
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genes, and genes related to extra cellular matrix (ECM) construction.  Biological 
process data is presented in Table 2.   
DISCUSSION 
 The limited number of biological replicates and tissue greatly reduced the 
power to detect differentially expressed genes.  Overlap in genes differentially 
expressed was low between different PMT levels.  Many genes were differentially 
expressed at 70 PMT compared to 80 PMT or 90 PMT.  This was likely because of 
photo saturation at higher PMTs and higher background related to photo saturation.   
We expect different genes to be expressed at different PMT levels for this reason. 
Thus, it possible for a gene to be differentially expressed, but only observed as 
differentially expressed at one PMT. Based on the p-value histogram in Figure 1, 
the 70 PMT level provides a more probable list of differentially expressed genes.  
However, genes detected as differentially expressed at the other PMT levels are not 
bad candidates to test for differential expression.  Based on the p-value histograms 
and FDR for the 80 and 90  
PMT levels, there are likely a higher proportion of false positively declared 
differentially expressed genes in these PMT levels.  Ideally more technical replicates 
would be performed to reduce standard errors for gene expression estimates.  More 
biological replicates would have been even more beneficial to detecting differences 
in expression.  The small proportion of genes expressed on the microarray also 
inflated the false discovery rate estimates greatly since all transcript probes were 
included in the FDR calculation. 
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Despite the shortcomings of this experiment, differentially expressed genes 
were discovered.  Previous real-time PCR work did validate two differentially 
expressed gene, collagen 2 (COL2) and collagen 10 (COL10).  Expression levels of 
COL2 at 80 PMT were 2.52 fold higher in PRKG2R678Z/R678Z cattle than PRKG2R678Z/+ 
animals (p<0.04).  These results are in the same direction and similar magnitude as 
measured by real-time PCR.  This is consistent with what was observed in the 
rodent dwarf PRKG2 mutants [2].  Expression levels of COL10 at 70 PMT were 3.87 
fold higher in dwarf animals (p<0.05), and also in the same direction as measured by 
real-time PCR. COL10 expression was not expected to be reduced in 
PRKG2R678Z/R678Z cattle based on cell culture data from rat PRKG2 null animals.  The 
increase in COL10 expression has now been confirmed with two different methods. 
Differences between subsections of tissues sampled, species or cell culture versus 
in vivo expression are likely the cause of this difference.  Small sample size also 
cannot be neglected as a potential source of error in determining expression 
differences.   
Several genes detected as differentially expressed are particularly not worthy 
because they agree with the published biology of PRKG2 or SOX9. The PRKG2 
gene was differentially expressed at the 90 PMT expression measurement.  PRKG2 
expression was 3.17 fold higher in wildtype animals than null animals (p<0.03).  
These results are consistent with the process of non-sense mediated decay in 
mRNA prematurely truncated by a non-sense mutation.  Additionally, COL9 (1.81 
fold increase in PRKG2R678Z/R678Z cattle at 90 PMT, p=0.05), and WNT5a (18.54 fold 
increase in PRKG2R678Z/R678Z cattle at 90 PMT, p<0.05) displayed changes in gene 
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expression compared to PRKG2R678Z/+ cattle consistent with their roles in bone 
growth and development [30-33].  Each of these markers is more highly expressed 
in proliferative cells than hypertrophic cells.  Since PRKG2 acts like a molecular 
switch in the transition from proliferative to a hypertrophic growth states, it is logical 
that dwarf animals would have higher expression levels of these markers than 
normal animals.   
 Several of these differentially expressed genes are known to have SOX9 
responsive promoter and enhancer elements, including COL2, COL10 and COL9 
[31, 33].   As more sequences are annotated, additional SOX9 regulatory regions 
could be discovered within the list of differentially expressed genes. Analysis of 
promoter elements would enrich the list of true differential expression based on 
known transcription factors. 
Among the biological processes with many differentially expressed genes was 
calcium transport.  Regulation of calcium transport is essential to bone mineral 
density and strength. The WNT and calcium pathways are closely tied to the MAPK 
signaling pathway [34]. One of the major regulators of calcium is the non-canonical 
WNT5a pathway.  Cell culture experiments have suggested that the WNT5a 
pathway may intersect with the cGMP/ p38 MAPK, non-canonical calcium pathway 
[34].  Close review of the data by hand revealed a number of WNT pathway genes 
were differentially expressed between PRKG2R678Z/R678Z vs. PRKG2R678Z/+ cattle.  
WNT genes alter the differentiation status of chondrocytes.  MAPK regulation is 
important in bone, because one of the key MAPK pathway components is FGFR3. 
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The FGFR3 gene is vital to endochondral ossification as observed in the allelic 
series of mutations that cause achondroplasia in humans.   
In the PRKG2R678Z/R678Z cattle, it is difficult to know if changes in gene 
expression are caused by loss of PRKG2 function, or the downstream 
consequences of no functional PRKG2. Excess cGMP and NO in the growth plate 
no longer utilized by PRKG2 may greatly alter growth plate physiological conditions.  
Alternatively, PRKG2 may provide a feedback mechanism to regulate cGMP and 
NO.  It is likely that free cGMP and NO are altering gene expression based on 
knowledge from previous studies [19, 34]. Changes in cGMP and NO may even be 
altering the MAPK system [32].  Regardless of the mechanism, PRKG2 would 
appear to play an important role in calcium transport and availability in the growth 
plate. 
One of the critical findings in the study of the KMI mini rat, PRKG2 null 
mutant, is that PRKG2 acts as a molecular switch to regulate proliferative gene 
expression. In PRKG2R678Z/R678Z cattle, many proliferation markers were up regulated 
in the dwarf (e.g. forkhead related genes, see Table 2). Changes were also 
observed in gene expression for genes related to extra cellular matrix (ECM) 
composition and actin cytoskeletal development (Table 2).  Many of these changes 
were likely due to improper timing of growth plate development. Developmental 
timing is critical  for proper bone development [35].   
 A few unique patterns in gene expression were observed.  Considerable up-
regulation of Golgi stack, processing and transport genes was observed in 
PRKG2R678Z/R678Z cattle.  A large number of brain and neuronal genes were 
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differentially expressed.  Many of these genes are ion channels that would be 
expected to show differential expression in the absence of PRKG2.  The growth and 
differentiation factor (GDF) 3 was one of these neuronal genes found to be 
differentially expressed.  GDF3 is involved in stem cell recruitment in bone as well as 
nerve development [36, 37].  It is possible that GDF3 may be signaled by PRKG2 for 
growth plate cartilage stem cell recruitment or maintenance. PRKG2 might regulate 
an ion signaling system similar to that provided by innervation that synchronizes 
developmental events in the growth plate based on waves of ion and cation in- and 
out-flow.    
CONCLUSIONS 
 PRKG2s global function makes it an important intracellular signaling system 
for dissection.  PRKG2 signaling impacts research in cancer, bone growth, brain 
function, cystic fibrosis, and mineral homeostasis.  Gene expression data from cattle 
indicated an up-regulation of genes associated with proliferation, including Col2, 
forkhead genes and COL9.  Differential expression of these genes agrees with the 
proposed model of PRKG2 regulation of proliferative gene expression in the growth 
plate.  A hypertrophic growth marker, COL10, was over-expressed in 
PRKG2R678Z/R678Z cattle compared to PRKG2R678Z/+ individuals.  This is the opposite 
of what was observed in rodent PRKG2 null models.  Results for both COL2 and 
COL10 were consistent in magnitude and direction with previously performed real-
time PCR experiments.  Nonsense mediated decay of the PRKG2 transcript was 
observed in dwarf animals, consistent with the premature stop codon in the Angus 
dwarves.  Pathway analysis indicates patterns in gene expression change in the 
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MAPK and WNT5a signaling systems.  Biological processes such as calcium 
transport, proliferation, Golgi transport, apoptosis, and ECM construction also show 
considerable changes in gene expression.  Intriguingly, a host of neuronal genes 
were differentially expressed with little indication as to what their role might be in the 
growth plate.   
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FIGURE AND TABLE LEGENDS 
 
FIGURE 1.   Histogram of p-values for A) 70 PMT, B) 80 PMT, and C) 90 PMT.  
The flat distribution of p-values is an indicator of low power to detect many 
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differentially expressed genes in the experiment.  The leftward skew in the data may 
be due to lack of technical replicates or parameter in the model. 
FIGURE 2.  Overview of genes differentially expressed at 70, 80, and 90 PMT.  
Numbers in overlapping sections are genes detected as differentially expressed in 
multiple PMT settings. 
TABLE 1.  Summary of gene networks with multiple genes showing differential 
expression in the growth plate. 
1Background corrected, dye intensity adjusted, median centered data presented  
2Dwarf= null PRKG2 function vs. Normal = wild-type PRKG2 
3Fold change calculated as e^|Dwarf-Normal| 
4Dwarf=up regulation in PRKG2 null, Normal = up regulation in wild-type PRKG2 
5Nominal p-value 
TABLE 2.  Summary of biological processes with differential expression in the 
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CHAPTER 5.  GENERAL CONCLUSIONS 
Dwarfism has been a devastating problem for the beef industry for more than 
60 years.  Beef producers have lost their livelihood over the suspicion that a bull or 
cow sold from their herd was spreading dwarfism. Commercial cattle breeders loose 
money on dwarves because they require more time to grow to harvest weight and 
often still have a smaller carcass than cattle of normal stature.  Prior to genetic 
testing, dwarf carriers were detected by test matings or pedigree checking for 
relatives who had produced dwarf progeny.  These methods were time consuming, 
costly, and sometimes ineffective.   
Angus producers have been awaiting a genetic test for dwarfism for many 
years.  Drs. Lush and Hazel of Iowa State spent considerable time trying to help 
beef producers eliminate dwarfism in the 1940s and 50s to no avail.  Unfortunately, 
despite their experience as foremost experts in animal breeding, the technology was 
not yet available to solve the dwarfism problem.  Advances in the field of molecular 
genetics finally provided the tools required to take the next step in the solving the 
problem of dwarfism in the cattle industry.  The interest to continue dwarfism 
research was created by the appearance of multiple Angus dwarf calves across 
several different ranches in the US in 2002. 
SUMMARY OF LINKAGE MAPPING ANALYSIS 
The strategy to find the genetic locus responsible for dwarfism was to assess 
genetic mutations known to cause dwarfism in cattle and then perform linkage 
analysis of chromosomes known to contain genes that cause dwarfism in humans.  
Previous research determined that genetic mutations known to cause dwarfism in 
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Japanese Brown and Dexter cattle were not responsible for Angus dwarfism. 
Therefore, linkage mapping analysis was used to localize the dwarfism locus.   We 
used the Elston-Steward algorithm for linkage mapping to accommodate missing 
genotypes and a small pedigree.  A LOD score of 7.34 between markers AFR227 
and BM4311 on Bos taurus autosome (BTA) 6 was observed.  Fine-mapping of this 
region focused on four candidate genes identified by comparison to the bovine-
human radiation hybrid map.  Genomic sequence for these four genes, bone 
morphogenetic protein (BMP) 2 kinase, BMP3, fibroblast growth factor 5 (FGF5), 
and cyclic guanidine monophosphate dependant, type II, protein kinase (PRKG2), 
was queried and assembled using the BLAST extension and alignment program 
(BEAP).  The discovery of a C/T nonsense mutation in the kinase domain of PRKG2 
was the turning point for development of a genetic marker for dwarfism.   
SUMMARY OF FUNCTIONAL ANALYSIS 
Transfection assays in cell culture and in vivo expression studies 
demonstrated that this R678Z mutation in PRKG2 prevented SOX9 mediated 
regulation of both collagen (COL) 2 (ex vivo and in vivo) and COL10 (in vivo).  A 
breeding experiment successfully produced six calves, from which the four dwarf 
and two normal animals phenotypes were successfully predicted prior to expression 
of the dwarfism phenotype.  The body of work presented in combination with data 
generated from PRKG2 knockout dwarf mice and naturally occurring PRKG2 mutant 
dwarf rats strongly indicate that the R678Z PRKG2 marker is a causative mutation 
for Angus dwarfism.   
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SUMMARY OF MICROARRAY ANALYSIS 
Since the dwarf Angus has an apparent null PRKG2 signaling system, it can 
be used as a model to better understand the global function of PRKG2.  Microarray 
data comparing PRKG2R678Z/R678Z, dwarf, versus PRKG2R678Z/+, normal, cattle growth 
plate gene expression was presented to address this task. We used a nominal 
p<0.05 significance level to declare genes as differentially expressed. Despite the 
limited power of this experiment caused by low embryo viability, several genes were 
verified as differentially expressed using real-time PCR and several very good 
candidate genes and pathways were detected as differentially expressed.  Changes 
in gene expression related to SOX9 transcription factor activity provide additional 
evidence that the PRKG2 mutation is preventing SOX9 transcription factor activity.  
Over-expression of COL2, COL9, and WNT5a in PRKG2R678Z/R678Z versus 
PRKG2R678Z/+ cattle was consistent with inappropriate expression of proliferative 
growth markers observed in the rat.  Furthermore, changes in calcium signaling, 
MAPK and WNT5a signaling pathways are logical based on published data related 
to cGMP and nitric oxide (NO) induced gene expression.  The MAPK and WNT 
pathways are of particular interest because of their relationship to human 
achondroplasia and chondrocytes differentiation.  It is plausible that PRKG2 may 
have feed back mechanisms that alter cGMP and NO levels, leading to such drastic 
changes in gene expression.  Assuming these differences in gene expression are 
verified by real-time PCR, the data would indicate that PRKG2 is a major player in 
growth plate calcium homeostasis.  The implication of this regulation would be 
relevant to the most common bone disease, osteoporosis.  Other changes in gene 
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expression have less obvious roles in growth plate development.  The number of 
genes differentially expressed in the Golgi and Golgi to endoplasmic reticulum 
transport process, and neuronal development present more questions than answers. 
Additional research is needed to understand how these processes might alter growth 
and development in the growth plate. 
RECOMMENDED APPLICATION OF THE PRKG2 R678Z MARKER 
The economic lose for each dwarf produced is very high.  Therefore, it would 
be advisable to use the PRKG2 R678Z marker to screen all bulls and cows used to 
produce seedstock cattle (parents heavily used for matings). Screening all bulls 
used for artificial insemination for the PRKG2 R678Z marker may be the most logical 
starting point to prevent dwarfism.  These bloodlines are the most widely used. In 
the near future, genotyping platforms that allow genetic testing of thousands of 
single nucleotide polymorphisms markers will become inexpensive. Since many beef 
breeds require DNA based parentage testing, it would be best to simply test all 
animals simultaneously for parentage and the PRKG2 R678Z marker.  A breed 
association could then make the appropriate indication of genetic defect status for 
each individual.  
Breeders would need to be given proper explanation of the recessive pattern 
of inheritance of dwarfism and the accuracy and methods of the PRKG2 R678Z 
marker test to allow effective use in the field.  It would not advisable to immediately 
remove or prevent registration of all dwarf carriers.  Animals carrying the PRKG2 
R678Z marker likely have favorable genetic attributes that should be preserved 
within the breed. The breeder should decide how to make the appropriate matings to 
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prevent carrier-to carrier matings that could produce dwarf calves.  This will prevent 
dramatic lose in genetic progress if genetically superior individuals carry the PRKG2 
R678Z marker. 
FUTURE RESEARCH 
Future research in PRKG2 will focus on intermediates in the PRKG2, SOX9 
signaling system.  In Angus dwarves, work is on going in collaboration with the 
University of Nebraska to understand how the R678Z PRKG2 mutation alters protein 
localization in growth plate and other tissues.   Continued analysis of expression 
data is needed to understand how PRKG2 mediated signaling may play a role in 
MAPK, WNT, or calcium cascades.  If confirmed, functional studies would be 
needed to demonstrate how PRKG2 is altering biological processes in the growth 
plate.  Besides continued research in bone, studies of PRKG2 function in skeletal 
muscle and lung are particularly interesting areas for further investigation.  Since 
PRKG2 regulates proliferation, it may alter the rate of myogenesis.  In the lung, 
PRKG2 acts as an important regulator of the cystic fibrosis transmembrane receptor 
system.  Therefore, PRKG2 has important implications to cystic fibrosis research.  
The global expression of PRKG2 would suggest the potential for conserved 
biological processes with different contexts on a tissue-to-tissue basis.  A 
comparison of gene expression across tissues could yield key pathway components 
of the PRKG2 signaling system that are used across tissues. 
CONCLUSIONS 
In conclusion, a causative mutation for Angus dwarfism was discovered in the 
kinase domain of PRKG2.  Linkage mapping, real-time PCR expression data, 
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breeding experiment results, and microarray results all strongly support this 
conclusion. The genetic test developed to assay the R678Z PRKG2 mutation was 
100% accurate in predicting the dwarfism status of six calves produced in the 
breeding experiment.  The microarray data also independently confirmed the real-
time PCR results for COL2 and COL10 over-expression in dwarves.  The immediate 
implication of these results is the development of a genetic marker to determine 
dwarf carriers prior to the production of dwarf calves.  The test will save producers 
considerable profit for each dwarf carrier identified.  Long-term implications of 
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